UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended: September 30, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from __________ to __________

 

Commission File Number: 001-40615

 

QUANTUM COMPUTING INC.

(Exact name of registrant as specified in its charter)

 

Delaware   82-4533053
(State or other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
 Identification No.)

 

215 Depot Court SE, Suite 215
Leesburg, VA
  20175

(Address of Principal Executive Offices)

  (Zip Code)

 

(703) 436-2121

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $.0001   QUBT   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒    No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒    No  ☐

 

Indicate by check mark whether the registrant is large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer  Accelerated filer 
Non-accelerated filer  Smaller reporting company 
    Emerging growth company   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes ☐    No

 

As of November 10, 2023, there were 75,097,249 shares outstanding of the registrant’s common stock.

 

 

 

 

 

 

QUANTUM COMPUTING INC.

 

TABLE OF CONTENTS

 

    Page No.
PART I.  FINANCIAL INFORMATION 1
 
Item 1. Unaudited Financial Statements 1
  Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 F-1
  Consolidated Statement of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 F-2
  Consolidated Statement of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2023 and 2022 F-3
  Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 F-5
  Notes to the Unaudited Consolidated Financial Statements F-6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 2
Item 3. Quantitative and Qualitative Disclosures About Market Risk 10
Item 4. Controls and Procedures 10
     
PART II. OTHER INFORMATION 11
   
Item 1. Legal Proceedings 11
Item 1A. Risk Factors 12
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 12
Item 3. Defaults Upon Senior Securities 12
Item 4. Mine Safety Disclosures 12
Item 5. Other Information 12
Item 6. Exhibits 12

 

i

 

 

PART I – FINANCIAL INFORMATION

 

Item 1.  Consolidated Financial Statements 

 

QUANTUM COMPUTING INC.

Index to the Consolidated Financial Statements

(Unaudited)

 

Description   Page  
     
Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 (unaudited)   F-1
Consolidated Statement of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 (unaudited)   F-2
Consolidated Statement of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2022 (unaudited)   F-3
Consolidated Statement of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2023 (unaudited)   F-4
Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 (unaudited)   F-5
Notes to the Consolidated Financial Statements (unaudited)   F-6

 

1

 

 

QUANTUM COMPUTING INC.

Consolidated Balance Sheets

(Unaudited)

 

   September 30,   December 31, 
   2023   2022 
ASSETS        
         
Current assets        
Cash and cash equivalents  $7,379,362   $5,308,466 
Accounts receivable   2,435    12,774 
Prepaid expenses   167,201    224,302 
Loans receivable   543,178    
-
 
Other current assets   17,339    42,105 
Subtotal current assets   8,109,515    5,587,647 
Fixed assets (net of depreciation)   2,958,287    975,169 
Other Assets          
Lease right of use   1,115,397    1,327,746 
Security deposits   129,045    60,271 
Intangible Assets-net of amortization   12,099,013    22,223,725 
Goodwill   64,921,294    59,125,773 
Subtotal Other Assets   78,264,749    82,737,515 
Total assets  $89,332,551   $89,300,331 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
           
Current liabilities          
Accounts payable  $1,130,739   $871,887 
Accrued expenses   1,030,357    3,559,981 
Deferred Revenue   12,000    
-
 
Lease liability   1,153,868    1,357,924 
Dividends payable - preferred   215,119    219,844 
Loans payable – short term   4,512,718    535,684 
Accrued interest – short term   34,125    
-
 
Current liabilities – subtotal   8,088,926    6,545,320 
           
Long term liabilities          
Loans payable – long term   
-
    7,632,998 
Accrued Interest – long term   
-
    225,282 
Long term liabilities – subtotal   
-
    7,858,280 
Total liabilities  $8,088,926   $14,403,600 
           
Stockholders’ equity          
           
Preferred stock, $0.0001 par value, 1,550,000 shares Series A Convertible Preferred authorized; 1,490,004 and 1,500,004 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively; 3,079,864 shares of Series B Preferred Stock authorized, 0 and 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively   149    150 
Common stock, $0.0001 par value, 250,000,000 shares authorized; 75,094,943and 55,963,334 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
   7,510    5,596 
Additional paid-in capital   170,479,502    151,163,909 
APIC-Beneficial Conversion Feature in Equity   4,898,835    4,898,835 
APIC-Stock Based Compensation   47,269,914    38,816,022 
Accumulated deficit   (141,412,285)   (119,987,781)
Total stockholders’ equity   81,243,625    74,896,731 
Total liabilities and stockholders’ equity  $89,332,551   $89,300,331 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-1

 

 

QUANTUM COMPUTING INC.

Consolidated Statement of Operations

(Unaudited)

 

   Nine Months Ended   Three Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Total revenue  $283,154   $134,370   $50,435   $37,646 
Cost of revenue   131,117    41,692    23,721    24,891 
Gross profit   152,037    92,678    26,714    12,755 
Salaries and Benefits   3,441,092    3,776,324    1,456,770    1,299,587 
Consulting   604,499    923,620    196,178    297,107 
Research & Development   4,817,707    3,141,520    1,698,399    1,266,489 
Stock Based Compensation   5,893,296    4,665,631    1,977,671    1,261,969 
Selling General & Administrative   4,709,564    5,936,871    2,365,213    2,721,596 
Operating expenses   19,466,158    18,443,966    7,694,231    6,846,748 
Loss from Operations   (19,314,121)   (18,351,288)   (7,667,517)   (6,833,993)
Other Income and Expense                    
Interest Income   218,698    45,187    125,718    1,160 
Interest Expense – Promissory Notes   528,564    18,320    128,419    18,320 
Interest Expense – Preferred dividends   645,952    669,375    215,119    223,125 
Interest Expense – Financing expenses   1,154,565    813,750    390,582    495,000 
Net Other income (expense)   (2,110,383)   (1,456,258)   (608,402)   (735,285)
                     
Income tax expense   
-
    
-
    
-
    
-
 
                     
Net loss  $(21,424,504)  $(19,807,546)  $(8,275,919)  $(7,569,278)
                     
Weighted average shares – basic   75,094,943    33,904,329    75,094,943    33,904,329 
Weighted average shares – diluted   96,646,401    68,903,577    96,646,401    68,903,577 
Loss per share – basic   (0.29)  $(0.58)   (0.11)   (0.22)
Loss per share – diluted   (0.22)   (0.29)   (0.09)   (0.11)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-2

 

 

QUANTUM COMPUTING INC.

Consolidated Statement of Stockholders’ Equity

For the Nine Months Ended September 30, 2022

(Unaudited)

 

   Preferred Stock   Common Stock   Additional Paid in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
BALANCES, December 31, 2021   1,545,459   $154    29,156,815   $2,916   $97,592,909   $(81,394,081)  $16,201,898 
Issuance of shares for cash   -    
-
    -    
-
    
-
    
-
    
-
 
Issuance of shares for services   -    
-
    -    
-
    
-
    
-
    
-
 
Preferred OID Amortization   -    
-
    -    
-
    212,500    
-
    212,500 
Stock Options   -    
-
    -    
-
    2,985,453    
-
    2,985,453 
Stock based compensation   -    
-
    -    
-
    
-
    
-
    
-
 
Net loss   -    
-
    -    
-
    
-
    (7,133,692)   (7,133,692)
BALANCES, March 31, 2022   1,545,459   $154    29,156,815   $2,916   $100,790,862   $(88,527,773)  $12,266,159 
Issuance of shares for cash   -    
-
    -    
-
    
-
    
-
    
 
 
Conversion of Series A Preferred to Common   (45,455)   (4)   47,728    4    
-
    
-
    
-
 
Merger consideration        
 
    -    
-
    83,083,867    
-
    83,083,867 
Derivatives & Warrants   -    
-
    -    
-
    
-
    
-
    
-
 
Preferred OID Amortization   -    
-
    -    
-
    106,250    
-
    106,250 
Stock Options   -    
-
    -    
-
    229,510    
-
    229,510 
Stock based compensation   -    
-
    -    
-
    
-
    
-
    
-
 
Net loss   -    
-
    -    
-
    
-
    (5,104,576)   (5,104,576)
BALANCES, June 30, 2022   1,500,004   $150    29,204,543   $2,920   $184,210,489   $(93,632,349)  $90,581,210 
Issuance of shares for cash   -    
-
    -    
-
    
-
    
-
    
 
 
Conversion of Series A Preferred to Common   -    
-
    -    
-
    
-
    
-
    
-
 
Merger consideration   1,925,392    193    4,699,786    470    (663)   
-
    
-
 
Derivatives & Warrants   -    
-
    -    
-
    
-
    
-
    
-
 
Preferred OID Amortization   -    
-
    -    
-
    
-
    
-
    
-
 
Stock Options   -    
-
    -    
-
    1,167,617    
-
    1,167,617 
Stock based compensation   -    
-
    -    
-
    
-
    
-
    
-
 
Net loss   -    
-
    -    
-
    -    (7,569,278)   (7,569,278)
BALANCES, September 30, 2022   3,425,396   $343    33,904,329   $3,390   $185,377,443   $(101,201,627)  $84,179,549 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-3

 

 

QUANTUM COMPUTING INC.

Consolidated Statement of Stockholders’ Equity

For the Nine Months Ended September 30, 2023

(Unaudited)

 

   Preferred Stock   Common Stock   Additional
Paid in
   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
BALANCES, December 31, 2022   1,500,004   $150    55,963,334   $5,596   $194,878,766   $(119,987,781)  $74,896,731 
Issuance of shares for cash   
-
    
-
    3,021,632    302    6,551,153    
-
    6,551,455 
Issuance of shares for services   
-
    
-
    1,500,000    150    2,324,850    
-
    2,325,000 
Conversion of Preferred   (10,000)   (1)   11,096    1    596    
-
    596 
Merger consideration   -    
-
    -    
-
    
-
    
-
    
-
 
Stock Options   -    
-
    -    
-
    1,675,707    
-
    1,675,707 
Net loss   -    
-
    -    
-
    
-
    (8,506,137)   (8,506,137)
BALANCES, March 31, 2023   1,490,004   $149    60,496,062   $6,049   $205,431,072   $(128,493,918)  $76,943,352 
Issuance of shares for cash   
-
    
-
    5,889,097    589    8,116,047    
 
    8,116,636 
Issuance of shares for services   -    
-
    -    
-
    
-
    
-
    
-
 
Conversion of Preferred   -    
-
    -    
-
    
-
    
-
    
-
 
Merger consideration   -    
-
    -    
-
    (3,600,315)   
 
    (3,600,315)
Stock options   -    
-
    -    
-
    2,030,277    
-
    2,030,277 
Stock based compensation   
-
    
-
    853,600    85    (1,935,051)   
-
    (1,934,966)
Net loss   -    
-
    -    
-
    
-
    (4,642,448)   (4,642,448)
BALANCES, June 30, 2023   1,490,004   $149    67,238,759   $6,724   $210,042,030   $(133,136,366)  $76,912,537 
Issuance of shares for cash   
-
    
-
    6,379,784    638    8,800,831    
 
    8,801,469 
Issuance of shares for services   -    
-
    -    
-
    
-
    
-
    
-
 
Conversion of Preferred   -    
-
    -    
-
    
-
    
-
    
-
 
Merger consideration   -    
-
    -    
-
    185,384    
 
    185,384 
Stock options   -    
-
    -    
-
    1,993,769    
-
    1,993,769 
Stock based compensation   
-
    
-
    1,476,400    148    1,997,005    
-
    1,997,154 
Net loss   -    
-
    -    
-
    
-
    (8,275,919)   (8,275,919)
BALANCES, September 30, 2023   1,490,004   $149    75,094,943   $7,510   $222,648,251   $(141,412,285)  $81,243,625 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-4

 

 

QUANTUM COMPUTING INC.

Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2023 and 2022

(Unaudited)

 

   Nine Months Ended 
   September 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss  $(21,424,504)  $(19,807,546)
Adjustments to reconcile net loss to net cash used in operating activities          
Depreciation   181,483    21,551 
Amortization of intangibles   543,492    1,749,190 
Stock based compensation   8,086,939    4,382,581 
Debt discount   374,314    
-
 
Changes in operating assets and liabilities (net of amounts acquired)          
Accounts receivable   10,338    (94,807)
Prepaid expenses   57,104    180,381 
Deferred revenue   12,000    
-
 
Other Assets   (43,178)     
Accounts payable   283,618    234,791 
Accrued expenses   (2,720,781)   6,727 
Dividends payable   (4,129)   105,671 
Operating lease liability   8,293    (18,829)
CASH USED IN OPERATING ACTIVITIES   (14,635,011)   (13,240,290)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Property and equipment   (2,164,600)   (166,206)
Security deposits   (68,774)   41,344 
Loans receivable   (500,000)   
-
 
Other current assets   
-
    2,652 
Net cash used for QPhoton, Inc. merger   
-
    (1,356,071)
CASH USED IN INVESTING ACTIVITIES   (2,733,374)   (1,478,281)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Notes payable   (4,030,279)   8,042,540 
Preferred stock OID accrual   
-
    318,750 
Proceeds from stock issuance (ATM facility)   23,469,560    
-
 
CASH PROVIDED BY FINANCING ACTIVITIES   19,439,281    8,361,290 
           
Net increase (decrease) in cash   2,070,896    (6,357,281)
           
Cash, beginning of period   5,308,466    16,738,657 
           
Cash, end of period  $7,379,362   $10,381,376 
           
SUPPLEMENTAL DISCLOSURES          
Cash paid for interest  $719,721   $
-
 
Cash paid for income taxes  $
-
   $
-
 
NON-CASH INVESTING ACTIVITIES          
   $
-
   $
-
 
           
NON-CASH FINANCING ACTIVITIES          
Common stock, preferred stock and warrants issued (net of forfeitures) in connection with QPhoton, Inc. merger   (3,785,699)   83,083,867 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-5

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Note 1 – Nature of the Organization and Business

 

Corporate History

 

Quantum Computing Inc. (“QCi” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from “IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to The Nasdaq Stock Market LLC. On June 16, 2022, the Company merged with QPhoton, Inc. (“QPhoton”), a developer of quantum photonic systems and related technologies and applications.

 

Nature of Business

 

The Company is a developer of nanophotonic-based quantum technology, offering real-world, affordable commercial applications. The Company was founded in 2018 by leaders in supercomputing, mathematics, and computer programming to solve the enormous challenge with quantum computing in terms of the high cost and lengthy times required for quantum software development. While much of the market focuses on Quantum Processing Unit (QPU) hardware, the Company’s experts realized that the quantum marketplace and vendors were limiting access to quantum computers due to the complexity of programming them. At the present time, only a very limited number of highly specialized quantum experts are able to use software development toolkits (“SDKs”) to create these critical programs and applications. The Company’s flagship software solution, Qatalyst, has enabled subject matter experts (SMEs) to run existing software on quantum processing units without the need for specialized programming with SDKs. As a result of the merger with QPhoton in June 2022, the Company is now able to offer its software capability that is embedded within its new hardware offering of photonic quantum computing systems and related services.

 

Liquidity

 

On October 28, 2022 the Company filed a shelf registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”), which was declared effective on November 8, 2022 (the “2022 shelf”). Under the 2022 Shelf at the time of effectiveness, the Company had the ability to raise up to $100 million by selling common stock, preferred stock, debt securities, warrants and units. On December 5, 2022, the Company entered into an At-the-Market Issuance Sales Agreement (the “ATM Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”) relating to the sale of its common stock, and incorporated the ATM Agreement into the 2022 Shelf by amendment that was declared effective January 10, 2023. On August 17, 2023, the Company and Ascendiant entered into an amendment (the “ATM Amendment”) to the ATM Agreement, increasing the amount of Common Stock the Company may offer and sell via the “at the market” equity offering program from $25,000,000 to $50,000,000 (the “ATM Upsize”). Following the ATM Upsize, the Company is able to offer and sell shares of Common Stock having an aggregate offering price of up to $27,362,717 via the “at the market” equity offering program. The Company filed a prospectus supplement, dated August 18, 2023 with the Securities and Exchange Commission (the “SEC”) in connection with the offer and sale of the shares pursuant to the ATM Amendment (the “Prospectus Supplement”).

 

Under the terms of the ATM Agreement, as amended, the Company may, but is not obligated to, offer and sell, from time to time, shares of common stock having an aggregate offering price of up to $50 million through Ascendiant. Sales of common stock, if any, will be made by any method permitted that is deemed an “at the market offering” as defined in Rule 415 under the Securities Act. The Company intends to use any net proceeds from the sale of securities for our operations and for other general corporate purposes, including, but not limited to, capital expenditures, general working capital, and possible future acquisitions. There were 15,290,513 shares of common stock sold under the ATM Agreement during the nine months ended September 30, 2023 and no shares of common stock sold under the ATM Agreement during the nine months ended September 30, 2022. As of September 30, 2023, the Company has utilized $23.5 million of the 2022 Shelf. The Company has approximately $76.5 million available under the 2022 Shelf and $26.5 million available under the ATM Agreement, as amended, as of September 30, 2023.

 

F-6

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Note 2 – Significant Accounting Policies:

 

Basis of Presentation and Principles of Consolidation:

 

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), including ASC 810, Consolidation. The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

The Company’s fiscal year end is December 31.

 

The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern for a period of one year from the issuance of these financial statements. For the period ended September 30, 2023, the Company had $283,154 in revenues, a net loss of $21,424,504 and had net cash used in operations of $14,591,833. Additionally, as of September 30, 2023, the Company had working capital of $20,589 and an accumulated deficit of $141,412,285. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of these unaudited financial statements. The financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.

 

Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company’s patent applications and ultimately achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investments or achieve an adequate sales level.

 

Cash and Cash Equivalents

 

Highly liquid investments with a maturity of three months or less when purchased are considered to be cash equivalents. As of September 30, 2023, the Company had invested $7,171,302 in highly liquid money market funds managed by Morgan Stanley. The Company maintains the balance of its operating cash in deposit accounts with high quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses on these deposits and believes it is not exposed to significant credit risk on cash.

 

Use of Estimates:

 

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the determination of reserves for accounts receivable, stockholders’ equity-based transactions and liquidity assessment. Actual results may differ from these estimates.

 

F-7

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Revenue

 

The Company recognizes revenue in accordance with ASC 606 – Revenue from Contracts with Customers, by analyzing contracts with its customers using a five-step approach:

 

  1. Identify the contract
     
  2. Identify the performance obligations
     
  3. Determine the transaction price
     
  4. Allocate the transaction price to the performance obligations
     
  5. Recognize revenue when performance obligations are satisfied

 

The Company recognized revenue in 2023 and in 2022 from contracts to perform professional services. Revenue from time and materials-based contracts is recognized as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from units-based contracts is recognized as the number of units delivered or performed during the period times the contractual unit price. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost-plus type contracts at this time.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable principally consists of amounts due from customers for work performed on contracts. The Company records accounts receivable at their net realizable value. Periodically the Company evaluates its accounts receivable to establish an allowance for doubtful accounts, when deemed necessary, based on the history of past write-offs, collections and current credit conditions. During 2022 certain accounts receivable, attributable to a single customer, were determined not to be collectible and management recorded an allowance for doubtful accounts and wrote off the uncollectible receivables against that account. The accounts receivable as of September 30, 2023 and December 31, 2022 are considered fully collectible and thus management has not recorded an allowance for doubtful accounts.

 

F-8

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Operating Leases - ASC 842

 

The Company has adopted FASB Accounting Standards Codification, or ASC, Topic 842, Leases (“ASC 842”) which requires the recognition of the right-of-use assets and relating operating and finance lease liabilities on the balance sheet. Under ASC 842, all leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases. The lease classification affects the expense recognition in the income statement. Operating lease charges are recorded entirely in operating expenses. Finance lease charges are split, where amortization of the right-of-use asset is recorded in operating expenses and an implied interest component is recorded in interest expense. The expense recognition for operating leases and finance leases under ASC 842 is substantially consistent with ASC 840. As a result, there is no significant difference in our results of operations presented in our consolidated income statement and consolidated statement of comprehensive income for each period presented.

 

We lease substantially all our office space used to conduct our business. At the inception of a contract we assess whether the contract is, or contains, a lease. Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

 

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of these criteria. Substantially all our operating leases are comprised of office space leases and as of December 31, 2022 and September 30, 2023 we had no finance leases.

 

For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. The lease liability represents the present value of the lease payments under the lease. The Company is currently leasing space in four locations, Arlington, VA, Leesburg, VA, Minneapolis, MN and Hoboken, NJ, and we have recognized right-of-use assets and lease liabilities accordingly. The right-of-use asset is initially measured at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. The lease liability is initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, our secured incremental borrowing rate for the same term as the underlying lease. For our real estate and other operating leases, we use our secured incremental borrowing rate. For our finance leases, we use the rate implicit in the lease or our secured incremental borrowing rate if the implicit lease rate cannot be determined.

 

Business Combinations

 

We account for business combinations under the acquisition method of accounting, following ASC 805, Business Combinations. This method requires the recording of acquired assets and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Results of operations related to business combinations are included prospectively beginning with the date of acquisition and transaction costs related to business combinations are recorded withing general and administrative expenses.

 

F-9

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Property and Equipment

 

Property and equipment are stated at cost or contributed value. Depreciation of furniture, software and equipment is calculated using the straight-line method over their estimated useful lives, and leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the lease term. The cost and related accumulated depreciation of equipment retired or sold are removed from the accounts and any differences between the undepreciated amount and the proceeds from the sale are recorded as a gain or loss on sale of equipment. Maintenance and repairs are charged against expense as incurred.

 

Research and Development Costs

 

Research and development costs include costs directly attributable to the conduct of research and development programs, including the cost of services provided by outside contractors, acquiring work-in-progress intellectual property, development, and mandatory compliance fees and contractual obligations. All costs associated with research and development are expensed as incurred.

 

Stock Based Compensation

 

The Company has adopted Accounting Standards Update (“ASU”) No. 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of ASC 718, Share-Based Payment, to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of ASC 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, and that ASC 718 does not apply to share based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606, Revenue from Contracts with Customers

 

Stock-based compensation expense is recorded for all option grants and awards of non-vested stock and recognized in the financial statements based on the grant date fair value of the awards granted. Stock-based compensation is recognized as expense over the requisite service period, which generally represents the vesting period. The Company calculates the fair value of stock options using the Black-Scholes option-pricing model at grant date. The Company estimates a rate of forfeiture when recording stock option expense. The assumptions and estimates involved in the Black-Scholes model require significant judgement and any changes could have a material impact in the determination of stock-based compensation expense

 

F-10

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Earnings (Loss) Per Share:

 

Basic earnings (loss) per common share (“EPS”) is based on the number of common shares outstanding during each period presented. Convertible securities, warrants, and options to purchase common stock are included as common stock equivalents only when dilutive. The Company follows the provisions of ASC 260, Diluted Earnings per Share. In computing diluted EPS, basic EPS is adjusted for the assumed issuance of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using the “treasury stock method,” which assumes that the “proceeds” from the exercise of these instruments are used to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred stock is calculated using the “if-converted method,” pursuant to which the securities are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the entire period being presented.

 

The Company had the following common stock equivalents at September 30, 2023 and 2022:

 

   September 30 
   2023   2022 
Common stock   75,094,943    33,904,329 
Series A preferred stock (as converted)   1,564,505    1,575,004 
Series B preferred stock (as converted)   
-
    19,253,920 
Warrants   6,391,024    8,594,796 
Stock options   13,595,929    5,575,528 
Total fully diluted common shares   96,646,401    68,903,577 

 

Note 3 – Business Combinations

 

Merger with QPhoton, Inc.

 

On May 19, 2022, the Company, QPhoton, and Yuping Huang, the principal stockholder of QPhoton (“Mr. Huang”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which the Company agreed to acquire QPhoton through a series of merger transactions (collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”). On June 16, 2022, all conditions precedent having been met or waived by the parties, the Company closed the Transactions with QPhoton. The merger with QPhoton adds to the Company’s portfolio of quantum computing products and enables the Company to offer a wider range of quantum information services. The Company accounted for the Transactions using the acquisition method in accordance with ASC 805, Business Combinations, with the purchase price being allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their respective estimated fair values on the acquisition date. Fair values were initially determined using management estimates at the time of the merger, then updated in June 2023 for the values attributable to intangible assets based on new information the Company received from a third party valuation. The results of QPhoton are included within the consolidated financial statements commencing on the acquisition date.

 

Pursuant to the Merger Agreement, immediately following the closing of the Transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub I (a wholly owned subsidiary of the Company) merged with and into QPhoton, with QPhoton surviving the merger as a wholly-owned subsidiary of the Company, immediately after which the surviving corporation merged with and into Merger Sub II (also a wholly owned subsidiary of the Company), with Merger Sub II surviving the merger as a wholly-owned subsidiary of the Company (the “Surviving Company”). The merger consideration to be paid to the stockholders of QPhoton (the “Merger Consideration”) consisted of (i) 5,802,206 shares of common stock, par value $0.0001 per share, (ii) 2,377,028 shares of a new series of the Company’s preferred stock, par value $0.0001 per share, to be designated Series B convertible preferred stock (“Series B Preferred Stock”), and (iii) warrants to purchase up to 7,028,337 shares of common stock (the “Warrants”). Each share of Series B Preferred Stock converts into ten (10) shares of common stock. The Merger Consideration for stockholders Yuping Huang and Stevens Institute of Technology was issued in 2022. The other stockholder may have forfeited his rights to the Merger Consideration when he filed a claim asserting Appraisal rights under Delaware law, and pursuant to the terms of the Merger Agreement, all claims to the Merger Consideration had to be submitted to the Company within twelve (12) months of the Closing. However, the Company is in settlement negotiations with the remaining QPhoton stockholder and has decided not to post any adjustment to the purchase price of the Transaction until those negotiations are concluded or abandoned.

 

F-11

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

The purchase price was approximately $83.1 million, consisting of Company Common Stock, Series B Preferred Stock and Warrants. The purchase agreement did not include any contingent consideration. Since the Transactions were structured as an exchange of equity securities, the purchase price was calculated based on the fair market value (in this case the NASDAQ closing price) of the total shares of the Company securities paid to the shareholders of the acquired company, QPhoton. The closing Price of Company Common Stock on June 16, 2022 was $2.27. The total shares of Company Common Stock offered for QPhoton was 36,600,823 – which assumes all of the 2,377,028 Series B Convertible Preferred shares are converted to Common Stock at the 10:1 ratio, and that all 7,028,337 warrants to purchase Common Stock are eventually exercised. The warrants were valued using a Black Scholes formula assuming a maturity of five years, a risk-free interest rate of 2.8%, a volatility of 3.54 and an exercise price of $0.00001. That results in a total value for the Transactions of $83,083,868. This amount will be used as the purchase price. Under ASC 805 transaction costs are required to be expensed so legal and accounting fees incurred for the Transactions were not included in the purchase price.

 

The fair value of the prepaid expenses and security deposits was set at book value, and the fair value of the fixed assets was written up to the purchase cost to reflect the recent purchase dates of the equipment relative to the closing date of the merger. To estimate the fair value of the identifiable intangible assets, the Company recorded an estimate at the time of merger. The Company subsequently engaged a third-party valuation expert (the “Third Party Valuation Expert”), Scalar, LLC, to conduct an independent analysis in line with purchase price accounting standards. The Third Party Valuation Expert concluded:

 

  that there was no fair value attributable to management’s initial estimate of $10,000,000 for customer relationships based on the lack of current customer contracts;

 

  a fair value of $2,722,000 attributable to the non-compete agreement with the founder using the with-and-without method, based on a variation of the income approach, an increase of $2,222,000 in intangibles compared with management’s initial estimate of $500,000. The with-and-without methodology employed uses two scenarios to value the non-compete asset: (1) the “with scenario” captures the estimated cash flows from the business if all of the existing assets were in place including the non-compete asset, and (2) the “without scenario” captures the estimated cash flows from the business if all of the existing assets were in place except the non-compete asset. The difference between the two scenarios is attributed to the presumed loss of cash flows without the non-compete asset in place and represents the value of the non-compete agreement;

 

  a fair value of $969,000 attributable to the QPhoton trade name and trademark using the relief from royalty methodology, a decrease of $31,000 in intangibles compared with management’s initial estimate of $1,000,000. In the application of the relief from royalty method, the Third Party Valuation Expert estimated the value of the trade names/trademarks by capitalizing the royalties saved by virtue of the Company owning the trade names/trademarks. In other words, the Company realizes a benefit from owning the intangible asset rather than paying a rent or royalty for the use of the asset;

 

  a fair value of $12,200,000 attributable to the technology and licensed patents using the relief from royalty methodology, an increase of $477,780 in intangibles compared with management’s initial estimate of $11,722,220. In calculating the fair value of the technology and licensed patents, the Third Party Valuation Expert followed the same approach as the trade name/trademark analysis; and

 

  that there was no identifiable intangible value attributable to management’s initial estimate of $2,250,000 for employee agreements, rather calculated a fair value of $1,912,000 included in goodwill attributable to the assembled workforce using the replacement cost method.  The replacement cost method approximates the cost it would take to reconstruct an asset of similar utility (to create a substitute asset). Specifically, this approach considers all of the costs the Company would have incurred to replace the QPhoton workforce with a brand new (but comparable) workforce. The assembled workforce value is added to goodwill per ASC 805-20-55-6, Assembled Workforce and Other Items that Are not Identifiable, and not tracked separately as an amortizing intangible asset.

 

The Company accepted the Third Party Valuation Expert’s valuation without adjustment.

 

The following table summarizes the adjusted acquisition date fair values of assets acquired and liabilities assumed by the Company, including the final results of the analysis performed by the Third Party Valuation Expert for the intangibles:

 

Purchase price, net of cash acquired  $81,939,939 
Less     
Prepaid expenses   16,109 
Fixed assets at cost   116,315 
Security deposits   97,768 
Non-compete agreement with founder   2,722,000 
Website domain, trade name and trademark   969,000 
Technology and licensed patents   12,200,000 
Accounts payable and other current liabilities   (2,888,246)
Goodwill  $68,706,993 

 

F-12

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

The purchase price and purchase price allocation for QPhoton was initially considered finalized as of September 30, 2022, then was subsequently revised after the Company received new information from the Third Party Valuation Expert’s valuation of intangibles. The following table summarizes the changes of intangibles, which resulted in an increase to goodwill of $9,581,220 compared to initial purchase price allocation estimates reported in the Company’s Form 10-Q: Quarterly report for quarter ending June 30, 2022.

 

   Initial
Valuation
   Final   Increase 
Intangible Assets  Estimate   Valuation   (Decrease) 
Customer relationships  $10,000,000   $
-
   $(10,000,000)
Non-compete agreement with founder   500,000    2,722,000    2,222,000 
Website domain, trade name and trademark   1,000,000    969,000    (31,000)
Employment agreements   2,250,000    
-
    (2,250,000)
Technology and licensed patents   11,722,220    12,200,000    477,780 
Total  $25,472,220   $15,891,000    (9,581,220)

 

Based on the adjusted purchase price allocation, the goodwill recognized was $68.7 million, which is not expected to be deductible for income tax purposes. The amount allocated to goodwill and intangible assets reflected the benefits the Company expected to realize from the growth of the acquisition’s operations. 

 

Note Purchase Agreement – the Company and QPhoton

 

On February 18, 2022, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with QPhoton, pursuant to which the Company agreed to loan money to QPhoton using two unsecured promissory notes (each, a “Note”), each in the principal amount of $1,250,000, subject to the terms and conditions of the Note Purchase Agreement. Also on February 18, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1,250,000 to QPhoton. On April 1, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1,250,000 to QPhoton, for a total loan under the two Notes of $2,500,000.

 

The Note Purchase Agreement contains customary representations and warranties by QPhoton and the Company, as well as a “most favored nations” provision for the benefit of the Company. The Notes issued under the Note Purchase Agreement, including the Notes issued on February 18, 2022 and April 1, 2022, provide that the indebtedness evidenced by the applicable Note bears simple interest at the rate of 6% per annum (or 15% per annum during the occurrence of an event of default, as defined in the Notes), and becomes due and payable in full on the earlier of (i) March 1, 2023, subject to extension by one year at the option of QPhoton, (ii) a change of control (as defined in the Notes) of QPhoton or (iii) an event of default. As a result of the merger, the Notes and accrued interest are eliminated through consolidation. However, the two Notes have not been forgiven or converted to equity.

 

Note 4 – Intangible Assets and Goodwill

 

As a result of the merger with QPhoton, the Company has the following amounts related to intangible assets:

 

   Intangible Assets as of:     
   September 30,   December 31,   Amortizable 
Amortizable Intangible Assets  2023   2022   Life 
Customer relationships   
-
    10,000,000    3 years 
Non-compete agreement with founder   2,722,000    500,000    3 years 
Website domain, trade name and trademark   969,000    1,000,000    5 years 
Employment agreements   
-
    2,250,000    2 years 
Technology and licensed patents   12,200,000    11,722,220    10 years 
Less: accumulated amortization   (3,791,987)   (3,248,495)     
Net intangible assets  $12,099,013   $22,223,725      

 

F-13

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

The aggregate amortization expense of the Company’s intangible assets for the periods ended September 30, 2023 and December 31, 2022 was $543,492 and $3,248,495, respectively, driven by the purchase price allocation adjustments to initial estimates realized in the period ended June 30, 2023. The Company expects future amortization expense to be the following:

 

   Amortization 
Balance of 2023  $2,132,993 
2024   2,843,991 
2025   2,352,518 
2026   1,936,657 
2027   1,831,682 
Thereafter (2028-2032)   2,423,167 
Total  $12,099,013 

 

The Company recorded goodwill resulting from the merger with QPhoton, calculated as the difference between the total purchase price and the value of tangible and intangible assets acquired less the liabilities assumed. The Company recorded goodwill of $65,106,678 resulting from the QPhoton merger. The following table provides a summary of the changes in goodwill for the periods ended September 30, 2023 and December 31, 2022:

 

   September 30,   December 31, 
   2022   2022 
Goodwill, at beginning of year  $59,125,773   $
-
 
Goodwill additions or adjustments   9,581,220    59,125,773 
Goodwill reduction or impairment   3,785,699    
-
 
Goodwill, at end of year  $64,921,294   $59,125,773 

 

The Company tested the intangible assets and goodwill for impairment as of December 31, 2022 and concluded there was no impairment of intangible assets or goodwill at that time. For the period ended September 30, 2023, the Company realized $3,785,699 in reductions to goodwill related to forfeitures of warrants issued and reserved in connection with the QPhoton merger on June 16, 2022 (“QPhoton Merger Consideration Warrants”). The QPhoton Merger Consideration Warrants are forfeited on a pro rata basis when and if stock options and warrants issued and outstanding as of June 15, 2022 are forfeited. Additionally, the Company increased goodwill, as a reclassification from intangible assets, by $9,581,220 to record the adjustments resulting from the Third Pary Valuation Expert’s valuation as compared to initial estimates in the QPhoton purchase price allocation in the period ended June 30, 2023.

 

Note 5 – Income Taxes:

 

The Company has made no provision for income taxes because there has been no taxable income.

 

FASB has issued Statement of Financial Accounting Standards Number 109 (“SFAS 109”), “Accounting for Income Taxes”, which requires a change from the deferred method to the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities.

 

   September 30, 
   2023   2022 
Net operating loss carry-forwards  $13,136,072   $8,369,585 
Valuation allowance   (13,136,072)   (8,369,585)
Net deferred tax assets  $
-
   $
-
 

 

At September 30, 2023, the Company had net operating loss carry forwards of approximately $13,136,072.

 

Net operating loss carryforwards are subject to limitations under Section 382 of the Internal Revenue Code and the Company anticipates that no more than an insignificant portion of this net operating allowance will ever be used against future taxable income. FASB Codification ASC 740 requires changes in recognition and measurement for uncertain tax positions. The Company has analyzed its tax positions and concluded that it is not aware of any uncertain tax positions. If this conclusion changes, the Company will assess the impact of any such changes on its financial position and the results of operations.

 

F-14

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Note 6 – Financial Accounting Developments:

 

Recently Issued Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. The Company has evaluated the recently implemented accounting standards and concluded that none currently apply to the Company.

 

Note 7 – Property and Equipment

 

   September 30,   December 31, 
Classification  2023   2022 
Hardware & Equipment  $3,171,835   $1,026,829 
Software   38,484    18,889 
Total cost of property and equipment   3,210,319    1,045,718 
Accumulated depreciation   252,032    70,549 
Property and equipment, net  $2,958,287   $975,169 

 

The Company acquired $2,164,601 of property and equipment during the nine months ended September 30, 2023. It is the Company’s policy to capitalize purchases of property and equipment with a cost of $2,500 or more that benefit future periods.

 

   Estimated
Useful Life
(Years)
 
Computer and laboratory equipment  5 
Network equipment  4 
Minor equipment  3 
Furniture and fixtures  7 
Software  3 
Leasehold improvements  5 

 

Maintenance and repairs are charged to operations when incurred. When property and equipment are sold or otherwise disposed, the asset account and related accumulated depreciation and amortization accounts are relieved, and any gain or loss is included in other income or expense.

 

Note 8 – Loans

 

Notes Payable – BV Advisory Partners, LLC

 

As part of our business combination with QPhoton in June 2022, we acquired a note payable to BV Advisory Partners, LLC. On March 1, 2021, QPhoton entered into a Note Purchase Agreement with BV Advisory. Under the Note Purchase Agreement, on March 1, 2021, March 23, 2021 and July 9, 2021, BV Advisory, a related party shareholder, purchased convertible promissory notes from QPhoton for $200,592, $150,000, and $150,000, respectively, for a total of $500,592 (the “BV Notes”). The BV Notes all bore interest at a rate of 6% per annum and matured 2 years from the grant date. However, QPhoton only received approximately $375,000 in cash proceeds as $125,041 was paid by BV Advisory directly to The Trustees of the Stevens Institute of Technology (“Stevens Institute”) on behalf of QPhoton, to satisfy QPhoton’s obligations to reimburse costs incurred under the terms of their patent license agreement with the Stevens Institute.

 

F-15

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

On June 16, 2022 the Company tendered a cashier’s check to BV Advisory in the amount of $535,68.44, representing the full principal balance of the BV Notes and accrued interest through June 16, 2022. On July 14, 2022 BV Advisory returned the cashier’s check and disputed the calculation of the amount paid to settle the BV Notes. The BV Notes and accrued interest are recorded as short-term liabilities. On August 15, 2022, BV Advisory Partners, LLC (“BV Advisory”) filed a complaint in the Court of Chancery of the State of Delaware naming the Company and certain of its directors and officers (among others) as defendants (the “Lawsuit”). BV Advisory Partners, LLC v. Quantum Computing Inc., et al., C.A. No. 2022-0719-VCG (Del. Ch.). BV Advisory is seeking, among other relief, monetary damages for an alleged breach of the Note Purchase Agreement between BV Advisory and QPhoton, Inc., the predecessor in interest to QPhoton, LLC, a wholly-owned subsidiary of the Company, as well as monetary damages for breach of an alleged binding letter of intent among Barksdale Global Holdings, LLC, Inference Ventures, LLC and QPhoton, Inc. The Company believes that BV Advisory’s claims have no merit and intends to defend itself vigorously. The Company filed a motion to dismiss the complaint in December 2022, and in March 2023 Plaintiff filed a second amended complaint. The Company filed a motion to dismiss the second amended complaint, oral argument was held on October 11, 2023 and at this time that motion is pending before the Court. The Company does not believe it is necessary to accrue an amount in addition to the principal and interest on the BV Notes at this time.

 

Unsecured Promissory Note

 

On September 23, 2022, the Company entered into a note purchase agreement (the “NPA”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which Streeterville purchased an unsecured promissory note (the “Note” or the “Streeterville Unsecured Note”) in the initial principal amount of $8,250,000. The Note bears interest at 10% per annum. The maturity date of the Note is 18 months from the date of its issuance (the “Maturity Date”). The Note carries an original issue discount of $750,000, which is included in the principal balance of the Note. If the Company elects to prepay the Note prior to the Maturity Date, it must pay to Investor 120% of the portion of the Outstanding Balance the Company elects to prepay.

 

Beginning on the date that is six (6) months after the issuance date of the Note, Streeterville has the right to redeem up to $750,000 of the outstanding balance of the Note per month (“Redemption Amount”) by providing written notice to the Company (“Redemption Notice”). Upon receipt of any Redemption Notice, the Company shall pay the applicable Redemption Amount in cash to Streeterville within three (3) trading days of the Company’s receipt of such Redemption Notice. No prepayment premium shall be payable in respect of any Redemption Amount. As of September 30, 2023, Streeterville has redeemed $4,750,000 of the outstanding balance of the Note.

 

Pursuant to the terms of the NPA, the parties provided customary representations and warranties to each other. Also, until amounts due under the Note are paid in full, the Company agreed, among other things, to: (i) timely make all filings under the Securities Exchange Act of 1934, (ii) ensure the common stock continues to be listed on the Nasdaq Stock Market LLC (iii) ensure trading in the common stock will not be suspended, halted, chilled, frozen, reach zero bid or otherwise cease trading on the Company’s principal trading market, (iv) ensure the Company will not make any Restricted Issuance (as defined in the Note) without Investor’s prior written consent, which consent may be granted or withheld in Investor’s sole and absolute discretion, (v) ensure the Company shall not enter into any agreement or otherwise agree to any covenant, condition, or obligation that locks up, restricts in any way or otherwise prohibits the Company from entering into certain additional transactions with Streeterville, and (vi) with the exception for Permitted Liens (as defined in the Note), ensure the Company will not pledge or grant a security interest in any of its assets without Streeterville’s prior written consent, which consent may be granted or withheld in Streeterville’s sole and absolute discretion.

 

The Note sets forth certain standard events of default (such event, an “Event of Default”) that generally, if uncured within seven (7) trading days, may result in the discretion of Streeterville in certain penalties under the terms of the Note. In this regard, upon an Event of Default, Streeterville may accelerate the Note by written notice to the Company, with the outstanding balance becoming immediately due and payable in cash at the Mandatory Default Amount (as defined in the Note). Additionally, upon written notice given by Streeterville to the Company, interest shall accrue on the Outstanding Balance beginning on the date the applicable Event of Default occurred at an interest rate equal to the lesser of fifteen percent (15%) per annum simple interest or the maximum rate permitted under applicable law upon an Event of Default.

 

Note Purchase Agreement Loan

 

On May 16, 2023, the Company entered into a Summary of Proposed Terms (the “Letter of Intent”) with millionways, Inc. (“millionways”) to provide bridge loans to millionways and enter into due diligence to acquire up to 100% of the AI firm. On June 6, 2023, the Company entered into a Note Purchase Agreement (the “MW Agreement”) with millionways, pursuant to which the Company agreed to purchase from millionways up to three unsecured promissory notes (each, a “MW Note”), in an aggregate principal amount of up to $2,000,000, subject to the terms and conditions of the MW Agreement. Also on June 6, 2023, pursuant to the terms of the MW Agreement, the Company purchased the MW Notes from millionways and loaned an aggregate principal amount of $500,000 to millionways.

 

The MW Agreement contains customary representations and warranties by millionways and the Company, as well as a “most favored nations” provision for the benefit of the Company. The MW Notes issued under the MW Agreement, including the MW Notes issued on June 6, 2023, provide that the indebtedness evidenced by the applicable MW Note bears simple interest at the rate of 10% per annum (or 15% per annum during the occurrence of an event of default, as defined in the MW Notes), and becomes due and payable in full on the earlier of (i) May 16, 2024, (ii) a change of control (as defined in the MW Notes) of millionways, (iii) dollar-for-dollar prepayment for additional capital received through any vehicle from a third party or (iv) an event of default. 

 

F-16

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Note 9 – Capital Stock:

 

Series A Convertible Preferred Offering

 

From November 10, 2021 through November 17, 2021, the Company conducted a private placement offering (the “Private Placement”) pursuant to securities purchase agreements with 7 accredited investors (the “Series A Investors”), whereby the Series A Investors purchased from the Company an aggregate of 1,545,459 shares of the Company’s newly created Series A Convertible Preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”) and warrants to purchase 1,545,459 shares of common stock for an aggregate purchase price of $8,500,000. The Private Placement was completed and closed to further investment on November 17, 2021.

 

The Series A Preferred Stock ranks senior to common stock with respect to the payment of dividends and liquidation rights. Each holder of Series A Preferred Stock is entitled to receive, with respect to each share of Series A Preferred Stock then outstanding and held by such holder, dividends at the rate of ten percent (10%) per annum (the “Preferred Dividends.”) The Company is obligated to pay the Preferred Dividends quarterly, in arrears, within fifteen (15) days of the end of each quarter. The Company has the option to pay the Preferred Dividends in cash or in common stock, at a price per share of common stock equal to the average of the closing sale price of the common stock for the five (5) trading days preceding the applicable dividend payment date. The Preferred Dividends are accrued monthly, but not compounded, and are recorded as interest expense, because the Preferred Dividends are mandatory and not declared at the discretion of the Board of Directors.

 

The number of shares of common stock issuable upon conversion of any share of Series A Preferred Stock shall be determined by dividing (x) the Conversion Amount of such share of Series A Preferred Stock by (y) the Conversion Price. “Conversion Amount” means, with respect to each share of Series A Preferred Stock, as of the applicable date of determination, the sum of (1) the stated value thereof plus (2) any accrued dividends. “Conversion Price” means, with respect to each share of Series A Preferred Stock, as of any optional conversion date, Mandatory Conversion Date or other date of determination, $5.50, subject to adjustment for stock splits, dividends, recapitalizations and similar corporate events.

 

The Warrants are two-year warrants to purchase shares of common stock at an exercise price of $7.00 per share, subject to adjustment, and are exercisable at any time on or after the date that is six (6) months following the issuance date. The warrants provide for cashless exercise in the event the underlying shares of common stock are not registered.

 

In connection with the Purchase Agreement, the Company and the Series A Investors entered into a registration rights agreement (the “Registration Rights Agreement”) pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days. Pursuant to the Registration Rights Agreement, the Series A Investors received certain rights, including but not limited to piggyback registration rights, providing that the holder be given notice of any proposed registration of securities by the Company, and requiring that the Company register all or any portion of the registrable securities that the holders request to be registered, in each case, subject to the terms and conditions of the Registration Rights Agreement.

 

On April 27, 2022 the Company filed a Resale Form S-3 as required by the Registration Rights Agreement, pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days from the closing of the Private Placement. The Resale Form S-3 went effective on June 2, 2022.

 

On June 13, 2022, one of the Series A Investors, Falcon Capital Partners, converted 45,455 shares of Series A Convertible Preferred stock into 47,728 shares of common stock.

 

F-17

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

On February 9, 2023, one of the Series A Investors, Greenfield Children, LLC, converted 10,000 shares of Series A Convertible Preferred stock plus accrued dividends into 11,096 shares of common stock.

 

Other Offerings

 

On October 11, 2022 the Company issued 155,000 shares of common stock to seven employees and consultants in exchange for services rendered.

 

On January 20, 2023 the Company issued 750,000 shares of common stock to Draper, Inc. and 750,000 shares of common stock to Carriage House Capital, Inc. as compensation for services rendered in support of the QPhoton merger.

 

On May 3, 2023 the Company issued 853,600 shares of common stock to thirty-five (35) employees as payment in lieu of cash for 2022 performance bonuses (the “Bonus Shares”). The Bonus Shares are restricted and will vest as follows: one half vesting on December 31, 2023 and one half vesting on December 31, 2024. As of September 30, 2023 the Company canceled 23,600 of the issued shares that were forfeited by employees no longer with the Company.

 

From January 19 through September 30, 2023, the Company sold 15,290,513 shares of common stock through its At-The-Market (ATM) facility, managed by Ascendiant Capital, at an average price of $1.53. The Company received gross proceeds of $23,469,560 and paid a fee of three percent (3%) to Ascendiant Capital.

 

Note 10 – Stock Based Compensation

 

Incentive Plans and Options

 

The Company’s 2019 Equity and Incentive Plan, as amended in 2021 (the “2019 Plan”) enabled the Company to grant incentive stock options or nonqualified stock options and other equity awards to employees, directors and consultants of the Company up to a total of 3,000,000 shares of common stock. All 3,000,000 shares available for issue under the 2019 Plan have been issued.

 

On July 5, 2022, the Board of Directors adopted the Company’s 2022 Equity and Incentive Plan (the “2022 Plan”) which provides for the issuance of up to 16,000,000 shares of common stock. The 2022 Plan was approved by a majority of the shareholders in September 2022. Per the 2022 Plan, the 2022 Plan reserves increased automatically by 1,000,000 shares on January 1, 2023, providing for a total issuance of up to 17,000,000 shares of common stock. As of September 30, 2023, a total of 13,595,929 shares and options were issued and outstanding under the 2022 Plan.

 

The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:

 

   Nine and Twelve
Months Ended
  
   September 30,  December 31,  
   2023  2022  
Exercise price  $ 1.351.84  $ 5.2012.72  
Risk-free interest rate   4.684.81%  0.040.08% 
Expected volatility   200214%  390415% 
Expected dividend yield   0%  0% 
Expected life of options (in years)   5.0   5.0  

 

The following table summarizes the Company’s option activity since December 31, 2022:

 

       Weighted     
       Average   Contractual 
   Number of   Exercise   Term 
   Shares   Price   (in years) 
Outstanding as of December 31, 2022   9,601,237   $3.42    4.0 
Granted   4,342,500    1.42    5.0 
Exercised   
-
    
-
    
-
 
Forfeited   347,808    5.77    
-
 
Outstanding as of September 30, 2023   13,595,929   $2.72    3.6 
Vested as of September 30, 2023   7,857,651   $3.37    3.3 

 

F-18

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

The following table summarizes the exercise price range as of September 30, 2023:

 

Exercise Price   Outstanding Options   Exercisable Options 
$1.00    408,970    408,970 
$1.35    3,750,000    
-
 
$1.45    225,000    225,000 
$1.67    50,000    16,665 
$1.84    592,500    300,000 
$1.95    280,000    280,000 
$2.37    5,090,459    4,388,447 
$2.40    1,055,000    525,006 
$2.56    287,500    95,822 
$2.61    150,000    97,226 
$3.58    65,000    43,335 
$3.98    66,000    66,000 
$5.69    12,500    12,500 
$5.70    25,000    16,667 
$6.49    50,000    33,333 
$6.85    650,000    566,675 
$7.00    18,000    12,000 
$7.55    7,500    7,500 
$8.85    100,000    66,670 
$10.00    650,000    650,000 
$11.51    50,000    33,335 
$11.65    12,500    12,500 
      13,595,929    7,857,651 

 

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2023 and twelve months ended December 31, 2022 was $1.42 per share and $2.38 per share, respectively. 

 

Stock-based compensation

 

The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss:

 

   Nine and Twelve
Months Ended
 
   September 30,
2023
   December 31,
2022
 
Research and development   2,273,846    2,758,465 
General and administrative   3,619,450    15,003,002 
Total stock-based compensation  $5,893,296   $17,761,467 

 

As of September 30, 2023, total unrecognized compensation cost related to common stock options was $7.0 million, which is expected to be recognized over a period of 4.3 years.

 

F-19

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Warrants

 

In connection with a restricted stock units offering in June 2020, the Company issued warrants in August 2020 to purchase 171,000 shares of common stock at an exercise price of $2.00/share. Those warrants are exercisable for five years from the date of issuance. In connection with an offering of Series A Convertible Preferred stock in November 2021, the Company issued warrants to purchase 1,545,459 shares of common stock at an exercise price of $7.00. Those warrants are exercisable for two years from the date of issuance. In connection with the QPhoton merger on June 16, 2022, the Company issued warrants to purchase 6,325,503 shares of common stock at an exercise price of $0.0001. Those warrants are exercisable when and if stock options and warrants issued and outstanding as of June 15, 2022 are exercised. The following table summarizes the warrants outstanding at September 30, 2023:

 

Issuance Date  Expiration Date  Exercise Price   Issued   Exercised   Forfeited /
Canceled
   Warrants
Outstanding
 
August 18, 2020  August 18, 2025  $2.00    171,000    (150,000)   
-
    21,000 
November 15, 2021  November 15, 2023  $7.00    1,545,459    
-
    
-
    1,545,459 
June 16, 2022  May 9, 2027  $0.0001    6,325,503    
-
    (1,500,938)   4,824,565 

 

Note 11 – Related Party Transactions

 

There were no related party transactions during the nine-month periods ended September 30, 2023 and 2022. 

 

Note 12 – Operating Leases:

 

The Company leases space in four different locations, Arlington, VA, Leesburg, VA, Hoboken, NJ and Minneapolis, MN, under lease agreements which expire at various dates through September 30, 2027. The Company’s leases do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease assets and liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease.

 

The table below reconciles the undiscounted future minimum lease payments under these operating leases to the total operating lease liabilities recognized on the consolidated balance sheet as of September 30, 2023:

 

Year  Lease
Payments
Due
 
Balance of 2023  $47,135 
2024  $344,732 
2025  $341,081 
2026  $349,608 
2027  $267,092 
Less: imputed Interest  $(301,334)
Present Value of operating lease liabilities  $1,048,313 

 

Other information related to operating lease liabilities consists of the following:

 

   Six and Twelve
Months Ended
 
   September 30,
2023
   December 31,
2022
 
         
Cash paid for operating lease liabilities  $314,498   $125,238 
Weighted average remaining lease term in years   3.9    4.7 
Weighted average discount rate   10%   10%

 

F-20

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

Note 13 – License Agreement – Stevens Institute of Technology

 

Effective December 17, 2020, QPhoton signed a License Agreement with the Stevens Institute. The License Agreement enables the Company to commercially use technology such as licensed patents, licensed patent applications and licensed “Know-How”. QPhoton is also able to issue sublicenses for the technology under the agreement. The agreement is effective until the later of: (i) the 30-year anniversary of the effective date, or (ii) the expiration of the licensed patent or licensed patent application that is last to expire. As part of the merger of the Company and QPhoton, the Stevens License Agreement was assigned to the Company.

 

During the term of the agreement and prior to any commercialization or sublicensing of the technology by the Company, the Company shall be required to submit annual reports to the Stevens Institute reporting on all research, development, and efforts toward commercialization and/or sublicensing made during the year. Once any commercialization and/or sublicensing has been initiated, the Company shall deliver quarterly reports to the Stevens Institute reporting on the revenue received by the Company, all sublicenses derived from the sale of licensed products, and the net sales price associated with each transaction. The Company will be responsible for reimbursing Stevens for any costs associated with the prosecution and maintenance of the licensed patents and licensed patent applications moving forward.

 

Consideration for the agreement

 

As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35,000 within 30 days of execution of the agreement, (ii) $28,000 within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the outstanding equity of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the net sales price of each licensed product sold or licensed by the company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.

 

As of September 30, 2023 the Company has begun to commercialize some of the licensed technology, though has not recorded any related revenue and hence has not incurred any royalty expenses payable to the Stevens Institute.

 

Note 14 – Subsequent Events:

 

On October 3, 2023, the Company’s Federal subsidiary, QI Solutions, demonstrated unprecedented capability to detect landmines up to 2.5 feet below dense underground surface. The successful validation of Quantum Photonic Detection and Ranging (QpDAR) VX3, conducted from September 11-14, 2023, in a field environment, mimicking real-world conditions – demonstrated, the ability of the VX3 sensor to harness Quantum Single Photon Detection (QSPD) to detect landmines and unexploded ordnances (UXOs) from surface level to depths up to 30-inches. Landmines are a pervasive legacy of war that kill thousands of innocent civilians every year. According to United Nations News, currently there are approximately 70 countries and territories contaminated by roughly 110 million landmines. Landmines kill and maim up to 1,000 to 2,000 people every month, most of whom are civilians and children. In many of the most affected areas of the world, where agriculture is the mainstay of the economy, landmines were planted in fields, forests, around wells, water sources and hydroelectric installations, making the farmland unusable or usable only at great risk NATO, Department of State humanitarian programs, and multiple countries in Europe and Southeast Asia have commenced engagements to bring this technology to the field immediately.

 

F-21

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

September 30, 2023

 

On October 31, 2023, the Company signed contracts for its first sales of its Reservoir Computer and its Quantum Random Number Generator products to its partners’ Assured Cyber Protection Ltd and AI firm millionways to enhance their AI capabilities. These sales kick off the Company’s commercial delivery of its computing technologies. The QCi Reservoir Computer is a first-to-market portable device with technology inspired by the power of quantum mechanics. The device can perform complex computational tasks with unprecedented speed and efficiency to facilitate data analysis, machine learning and artificial intelligence. Its minimal size, weight, power, and cost factors make it particularly suitable for use as an edge computing tool. QCi’s Reservoir Computer uses the Company’s proprietary capabilities to create a small footprint hardware device that requires 80% to 95% less power consumption than conventional silicon-based computers. Additionally, the QCi Quantum Random Number Generator (QRNG) enables true randomness for applications in cryptography, secure communications, and data encryption. By integrating QCi’s Reservoir Computer and QRNG into their security algorithms, Assured Cyber Protection Ltd aims to enhance its ability to detect and respond to cyberattacks in real-time, staying ahead of cybercriminals in this ever-shifting landscape. The addition of QCi’s Reservoir Computer to millionways’ assessment process is expected to significantly boost machine learning efficiency, particularly in assessing audio files, dramatically reduce the power consumption and materially speed up the “training” of machine learning models.

 

On July 27, 2023, BV Advisory Partners, LLC, and its chief executive officer, Keith Barksdale, alleged stockholders of and claimants against the Company, filed a petition in the Court of Chancery of the State of Delaware to appoint a receiver for the Company (the “Petition”) based on allegations that the Company is insolvent. The Petition also objects to the Company’s approach to raising capital. In a related motion, the petitioners also sought expedited treatment of the petition on July 28, 2023 under the presumption that they allegedly face a threat of irreparable harm. The Company has strong defenses against the allegations in the Petition, considers the claims baseless and without merit, has moved to dismiss the Petition, and intends to vigorously defend itself against these baseless allegations. Among many other issues, the Company opposes the Petition in light of the fact that two of Mr. Barksdale’s own companies either filed for bankruptcy or were sold under Sheriff Auction within the last 12 months. Following oral arguments before the Delaware Chancery Court on October 11, 2023, the presiding judge denied BV Advisory Partners’ motion to expedite and took the Company’s motion to dismiss the Petition under advisement.

 

From October 1, 2023 through November 10, 2023, the Company repaid $1,500,000 of principal and accrued interest on the Streeterville Note, for a cumulative redemption amount of $6,250,000. As of November 10, 2023, the remaining principal and accrued interest payable is $2,786,528.

 

There are no other events of a subsequent nature that in management’s opinion are reportable.

 

F-22

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This quarterly report on Form 10-Q and other reports filed Quantum Computing, Inc. (the “Company,” “QCi,” “we,” “our,” and “us”) from time to time with the U.S. Securities and Exchange Commission (the “SEC”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the filings, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, relating to the Company’s industry, the Company’s operations and results of operations, and any businesses that the Company may acquire. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

 

Overview

 

Quantum Computing Inc. is a nanophotonic-based quantum technology company. Our mission is to be the democratizing force that brings quantum solutions to business, academia, government, and ultimately individual users. Our quantum technologies enable end users to get answers to critical business problems today, using the quantum solutions that deliver solutions otherwise unavailable in the market.

 

The Company was formed in 2018, to focus on providing a software platform to connect end-users with several commercially available quantum computers. The growth of our business was dependent on the ability of those quantum computers to provide viable business solutions that they were then, and today still are, incapable of providing. Consequently, in June 2022, the Company dramatically expanded the scope of its business through its merger with QPhoton, Inc. (“QPhoton”). By combining QPhoton’s quantum hardware intellectual property with QCi’s quantum software platform and its expertise in various quantum hardware platforms, the Company has transformed into a full-stack innovative solutions company providing quantum technologies in high-performance computing, remote sensing, imaging and cyber security. We believe that QCi, with its breadth of quantum technologies that are, all based on its core photonic computing capability of measuring, conditioning and manipulating single photons, is well-positioned, to address multiple quantum technology market areas that few of its competitors can claim. We believe that the key to our competitive advantage over other quantum computing hardware is the ability of our products to operate at room temperature with no expensive specialized cryogenic cooling, controlled noise and vibration free environments.

 

The first of the Company’s technology, the Dirac series, is the Company’s Entropy Quantum Computing (“EQC”). The Dirac series includes room-temperature, photonic quantum information processing systems underpinned by a series of patented and patent pending technologies. We believe that this will enable us to develop and produce multiple generations of information processors with increasing computational power, capacity, and speed, as well as the hardware miniaturization that will exceed the computing capabilities of current conventional high-performance computing systems, which are based solely on silicon chips and don’t use quantum effects when processing information. Our product development goals are to both (1) deliver compelling performance advantages over and (2) to eventually be able to solve complex problems more effectively and efficiently in terms of scalability, power consumption, and cost compared to such conventional systems. Our technology, supported by professional services through our “Quantum Solutions” offering, benefits our clients by providing a cloud-based pathway to access and adopt quantum technologies.

 

The Company’s products are in early commercialization. Revenues to date have consisted of professional services that utilize the Dirac-series computers and other prototype design and configuration services. We expect hardware sales to commence in the fourth quarter of 2023. 

 

2

 

 

In addition, our photonic technology and engineering teams are enabling QCi to continue to expand its product line into adjacent computing markets by using quantum effects and technology to produce enhanced LiDAR, vibrometry and sensing systems, imaging systems, cybersecurity and secured network solutions, and photonic

chips. Several of these technologies are already in early stages of commercialization.

 

While we are continuing to develop and improve our technology, our short-term goals and core business model are based on generating revenue from selling access to our advanced quantum computing systems (via the cloud) and on premise, both available with support from our Quantum Solutions team. As previously stated, we are developing commercial quantum imaging, sensing, and cybersecurity products that we are offering to both commercial and government clients. The Company’s near-term model is focused on selling desktop or rack-sized as well as portable quantum devices that will power hybrid computing systems that will create the combination of conventional computing and quantum computing to deliver alternative problem-solving solutions. Our long-term product goal is to build laptop quantum computers at price points that will make them affordable to computer users at every business level, not just the largest companies that can afford to spend significant sums to obtain better technology. We currently offer access to our quantum computing machines via our own in-house cloud service and have begun the process to be able to take orders for select hardware and device products.

 

A central capability that will drive our entire product development is our quantum nanophotonic chip technology. The Company already produces its own lithium niobate nanophotonic circuits and has plans to scale production to meet the requirements of our product roadmap as well as projected demand for our technologies. As further discussed below, the Company has announced plans to construct and operate a new state-of-the-art quantum nanophotonics technology manufacturing and research center.

 

We are focused on providing integrated quantum information gathering, transmission, and processing solutions, including both the user interface software and the quantum hardware. With our proprietary nanophotonic quantum technologies designed using our solution-oriented system architectures, we believe that we will have a competitive advantage in the market. As an integrated engineering team that works across multiple quantum technology domains, we believe that we are well-positioned to leverage our expertise in software, hardware, and nanophotonic circuits to develop quantum services and products, from quantum chip design and manufacturing through cloud delivery and eventually sales of hardware systems. We believe that this full-stack development approach offers both the fastest and lowest risk path to building commercially valuable quantum machines.

 

Market Opportunity

 

For the past 45 years or so, silicon-based processor manufacturers have been able to double their processing power every 18 to 24 months, a phenomenon known in the computer industry as “Moore’s Law.” Recently, the computer processor industry has found it increasingly difficult to offer faster, more powerful processors due to fundamental physical effects limiting further size reduction of transistors, according to We’re not prepared for the end of Moore’s Law, MIT Technology Review, February 2020; https:// www.technologyreview.com/2020/02/24/905789/ (Information contained on, or that can be accessed through, this website is not incorporated by reference in this Quarterly Report, and you should not consider information on this website to be part of this Quarterly Report). Despite this progress in transistors and computing power, many of the world’s most important computational problems are still considered impractical to solve using computer technology that is available today and that is expected to be available in the foreseeable future.

 

With this in mind, quantum computing represents a potential alternative approach to the hard limits now being approached by conventional computers that utilize silicon-based processors. This is because quantum computers apply the properties of quantum physics to operate in a fundamentally different way. Conventional computer chips use binary bits (ones and zeros) to represent information. Quantum computers utilize qubits, which leverage some of the properties of quantum physics to potentially process computations that would otherwise be intractably difficult using conventional computers.

 

Research suggests that quantum computers may be ideally suited to run optimization algorithms, where further advancements in approaches and quantum computing hardware could result in computational benefit over currently used conventional systems. See Quantum Computing for Finance: Overview and Prospects, https://www.sciencedirect.com/science/article/pii/S2405428318300571 (Information contained on, or that can be accessed through, this website is not incorporated by reference in this Quarterly Report, and you should not consider information on this website to be part of this Quarterly Report). The ability to solve challenging computational problems in a reasonable period of time is of particular interest in compute-heavy fields that include, among others, big data, artificial intelligence, healthcare, and cybersecurity. We believe that these are natural markets for quantum computing, due to the immense compute power required to process large data sets.

 

However, quantum technologies (particularly QCi’s) reach far beyond computing. Other aforementioned adjacent technologies in domains such as imaging, sensing, and cybersecurity will greatly benefit from the advances of quantum science to bring better technologies in medicine, engineering, autonomous vehicles, and cyber security to protect the most sensitive national and commercial systems from quantum enabled attacks. We believe that these markets will likely outpace and outperform the computing market in the near term and likely for the foreseeable future.

 

3

 

 

Strategy

 

QCi’s strategy has evolved to become a nanophotonic quantum solutions company, regularly launching an increasing selection of products and services. When QCi was formed, quantum computing was a fundamentally new paradigm compared with conventional computing, requiring a new and highly technical set of skills to create the hardware and software to drive quantum results. The pool of people with those skills is limited, in high demand and expensive. In addition, the predominant quantum computer programming approach, using one or more software development toolkits (“SDKs”) to create a quantum computing program, was and continues to be, slow and costly, and therefore poorly suited for non-quantum experts attempting to solve real world problems. Moreover, many types of quantum computing hardware require delicate and expensive cryogenic isolation systems just to maintain stability, which makes it difficult for users to interact with quantum computing systems. Until recently, the use of quantum computing was generally limited to research and science experiments conducted at universities and laboratories. A larger user community is now emerging, demanding greater capabilities from quantum systems. QCi is helping to drive that shift in the market with its available computing technologies, and we believe that QCi is prepared to address this growing need.

 

QCi’s merger with QPhoton, combined with QCi’s significant intellectual property work that culminated in the development of our Qatalyst software, enables the Company to offer room temperature quantum computation systems through cloud services today and, we expect, will enable us to offer affordable, turn-key products in the future as well. This combination of quantum hardware and software will address the steep learning curve and highly particular skillsets generally associated with quantum information processing, which have historically presented significant barriers to adoption for companies and government entities looking to leverage novel quantum computing capabilities to solve problems. We believe that QCi’s core proprietary photonic methodology offers:

 

  significant advantages to existing quantum technologies, including greater speed and processing power to tackle extremely large amounts of data with higher accuracy;
     
  scalability and compatibility with existing infrastructure;
     
  significantly lower power consumption; and
     
  smaller device footprint requiring no special conditions such as cryogenic temperatures or zero vibration levels. 

 

In short, our core technology offers practical, cost-effective solutions that materially advance the computing capability available in the market. We leverage this core competency across our five product platforms that include:

 

  1. Quantum Computing;

 

  2. Quantum Intelligence;

 

  3. Quantum Remote Sensing Quantum;

 

  4. Cyber Security; and

 

  5. Quantum Imaging.

 

4

 

 

Quantum Optical Chips – leveraged across all five product platforms and a key component to future product development

 

We believe that nanophotonic chips will ultimately provide the greatest scalability and performance advantages for quantum information processing, sensing and imaging. We continue to develop our proprietary nanophotonic chip designs and are actively working on the specification and design for a dedicated chip fabrication facility to develop and produce lithium niobate nanophotonic chips (“Quantum Optical Chips”) for quantum information processing and other single photon detection and sensing applications. Our plan for the facility is to produce a range of Quantum Optical Chips for use in our own products and for general sale in the market. With respect to building such a facility, QCi believes that we have an opportunity to benefit from the CHIPS and Science Act of 2022 (the “CHIPS Act”), which allocates $52 billion for the revitalization and onshoring of semiconductor manufacturing in the U.S. During 2023, we began to take steps to establish a U.S.-based chip facility. We have submitted a letter of interest and are progressing in the grant application process. We have also secured an optimum site location at the ASU Research Park in Tempe, Arizona and have placed deposits to secure certain long-lead time equipment. QCi is prepared, however, to finance some or all of the required funding to build the facility, if necessary, and believes that it has multiple sources available to do so. Currently, QCi leases facilities to develop Quantum Optical Chips and has secured additional capabilities to scale in order to meet anticipated future demand until our new fabrication facility is completed and operational, which is dependent on permitting and supply chain factors.

 

We believe that QCi’s ability to sell its innovative solutions in the marketplace would be enhanced by partners who represent significant experience and success in their respective domains. QCi is continuing to expand its partner base to address opportunities in the federal government, including the Department of Defense as well as civilian federal government agencies, and the commercial sector, including major firms with successful business lines in the medical, civil engineering, and supply chain domains, among others.

 

The U.S. government recognizes that quantum technologies are essential to maintaining technology leadership in the world today. See the National Strategic Overview for Quantum Information Science, https://www.quantum.gov/wp-content/uploads/2020/10/2018_NSTC_National_Strategic_Overview_QIS.pdf, on the National Quantum Initiative website. In order to fully support tremendous potential for our market-ready quantum solutions to this important market, in February 2023 QCi launched a wholly owned subsidiary, QI Solutions, Inc. (“QiS”), to deliver quantum products and services to the U.S. government agencies and defense markets to best serve the unique requirements of this market. QiS is strategically headquartered in Arizona, a leading force in the field of optics whose government leaders are early champions of advanced photonic research, supporting strong research universities interested in exploring mission-ready quantum computing and related technologies. Furtermore, in September 2023, QiS, signed a five-year Overarching Cooperative Research and Development Agreement (OCRADA) with U.S. Special Operations Command (USSOCOM) to develop quantum technology applications in support of USSOCOM programs. USSOCOM is the premier entity of the U.S. Department of Defense that deploys the world’s latest technology to conduct global special operations and activities as part of the Joint Force, in concert with the U.S. government interagency, allies, and partners. QiS will work with USSOCOM’s Science & Technology Directorate on the development of advanced quantum solutions for use by Special Operations Forces in their unique mission roles.

 

We believe that our unique capabilities that can be adopted for immediate applications are appropriate for multiple programs within various government departments and agencies and anticipate that we could soon see our solutions utilized in a wide variety of boutique applications for our clients. To illustrate, in July 2023, the Company received a NASA Ames subcontract award from Bay Area Environmental Research Institute (BAERI) to build and test an innovative photonic sensor instrument that provides accurate measurement of atmospheric particulates such as clouds, aerosols, smoke flume, volcanic ashes, etc. to identify physical properties including size, shape and chemical composition. This award represents the third distinct task order from NASA in 2023 and is the second research center within NASA to subcontract with the Company. Under the nine-month subcontract, QCi will deliver a compact system, programmed to process a substantial amount of data that can support standalone operations for days, and designed to be powered by a 12-volt battery that consumes no more than 30 watts of power. The possible long-term objective of this engagement is to position these instruments for field deployment to create a monitoring network.

 

5

 

 

Industry Trends

 

Our industry is dynamic and highly competitive, with frequent changes in both technologies and business models. Each industry shift is an opportunity to conceive new products, new technologies, or new ideas that can further transform the industry and our business. At QCi, we push the boundaries of what is possible through a broad range of research and development activities that seek to identify and address the changing demands of customers and users, industry trends, and competitive forces.

 

Economic Conditions, Challenges, and Risks

 

The markets for high-performance conventional and quantum computing and cloud-based services are dynamic and highly competitive. Our competitors are developing new computing devices, while also enhancing competing cloud-based services for businesses. Aggregate demand for our solutions, services, and devices is also correlated to global macroeconomic and geopolitical factors, which remain dynamic. We must continue to evolve and adapt over an extended time in pace with this changing environment.

 

The investments we are making in Quantum Optical Chips and devices will continue to increase our operating costs and may decrease our operating margins. Components for our devices are primarily manufactured by third-parties. Some of our products contain certain components for which there are very few qualified suppliers. Extended disruptions at these suppliers could impact our ability to manufacture devices on time to meet consumer demand.

 

Our success is highly dependent on our ability to attract and retain qualified employees. We hire a mix of university and industry talent. We compete for talented individuals by offering an exceptional working environment, an ability to work on new, ground-breaking quantum technology, the ability to grow one’s career across many different products and businesses, and competitive compensation and benefits.

 

Results of Operations

 

Three Months Ended September 30, 2023 and 2022

 

The following table summarizes the highlights of our financial performance for the three months ended September 30, 2023 and September 30, 2022 as well as the increase (decrease) and percentage changes between the periods presented:

 

   Three Months
Ended
September 30,
2023
   Three Months
Ended
September 30,
2022
   Dollar
Change
   Percentage
Change
 
Revenue  $50,435   $37,646   $12,789    34%
Cost of revenue   23,721    24,891    (1,170)   (5)%
Operating expenses   7,694,231    6,846,748    847,483    12%
Loss from operations   (7,667,517)   (6,833,993)   833,524    12%
Other income (expenses)   (608,402)   (735,285)   (126,883)   (17)%
Net loss   (8,275,919)   (7,569,278)   (706,641)   9%
Loss per common share – basic  $(0.11)  $(0.22)  $0.11    50%

 

6

 

 

Revenues

 

   Three Months
Ended
September 30,
2023
   Three Months
Ended
September 30,
2022
   Increase
(Decrease)
   Percentage
Change
 
Products  $0   $0   $0    0%
Services   50,435    37,646    12,789    34%
Total  $50,435   $37,646   $12,789    34%

 

Revenues for the three months ended September 30, 2023 were $50,435 compared to $37,646 for the comparable prior year period, an increase of $12,789 or 34%. The increase in revenues is primarily due to changes in the number and size of active customer contracts and the level of effort performed on each one during the periods. Revenue in the current reporting period is derived from professional services provided to multiple government and commercial customers under multi-month contracts.

 

Cost of Revenues

 

Cost of revenues, which consists of direct labor expenses, primarily salary expense for engineering and solutions staff delivering services, was $23,721 for the three months ended September 30, 2023 compared to $24,891 for the comparable prior year period, a decrease of $1,170 or 5%. The decrease is primarily due to the decrease in direct labor expense required to perform on the contracts in the current quarter compared to the prior year period.

 

Gross Profit/Gross Margin

 

Gross profit and gross margin for the three months ended September 30, 2023 was $26,714 and 53%, respectively, compared to $12,755 and 34%, respectively, for the comparable prior year period, an increase of $13,959 and 109%, respectively. The increase in gross profit is primarily due to the increase in gross revenue during the three months ended September 30, 2023 compared to the prior year period, and the increase in gross margin is primarily due to the decrease in the amount of direct labor required to perform the contracted services in the current period.

 

Operating Expenses

 

Operating expenses consist of payroll and employee benefits, external contractor, consulting and professional services costs, stock-based compensation expense and general and administrative expenses, including other headcount-related expenses associated with finance, legal, human resources and other administrative personnel, depreciation and amortization, certain taxes, and legal and other administrative fees. Operating expenses for the three months ended September 30, 2023 were $7,694,231 compared to $6,846,748 for the comparable prior year period, an increase of $847,483 or 12%. The increase in operating expenses compared to the comparable prior year period is due in large part to the $872,885 net increase in combined stock-based compensation and salary expenses and the $431,910 increase in research and development expenses for additional technical labor, parts and supplies needed to design and test new hardware products, offset by the $356,383 decrease in other SG&A costs driven by lower intangibles amortization related to the QPhoton merger and the $100,929 decrease in consultant expense driven in large part by our trend to increasingly use full and part time employees to perform work for which we previously relied on consultants.

 

Net Loss

 

Our net loss for the three months ended September 30, 2023 was $8,275,919 compared to a net loss of $7,569,278 for the comparable prior year period, an increase of $706,641 or 9%. The increase in net loss is primarily due to the changes in operating expenses discussed above, which were offset in part by the $124,558 increase in interest income related to the Company’s cash and equivalents invested in highly liquid money market funds.

 

7

 

 

Nine Months Ended September 30, 2023 and 2022

 

The following table summarizes the highlights of our financial performance for the nine months ended September 30, 2023 and September 30, 2022 as well as the increase (decrease) and percentage changes between the periods presented:

 

   Nine Months
Ended
September 30,
2023
   Nine Months
Ended
September 30,
2022
   Dollar
Change
   Percentage
Change
 
Revenue  $283,154   $134,370   $148,784    111%
Cost of revenue   131,117    41,692    89,425    214%
Operating expenses   19,466,158    18,443,966    1,022,192    6%
Loss from operations   (19,314,121)   (18,351,288)   (962,833)   (5)%
Other income (expenses)   (2,110,383)   (1,456,258)   (654,125)   (45)%
Net loss   (21,424,504)   (19,807,546)   (1,616,958)   (8)%
Loss per common share – basic  $(0.29)  $(0.58)  $0.29    50%

 

Revenues

 

   Nine Months
Ended
September 30,
2023
   Nine Months
Ended
September 30,
2022
   Increase
(Decrease)
   Percentage
Change
 
Products  $0   $0   $0    0%
Services   283,154    134,370    148,784    111%
Total  $283,154   $134,370   $148,784    111%

 

Revenues for the nine months ended September 30, 2023 were $283,154 compared to $134,370 for the comparable prior year period, an increase of $148,784 or 111%. The increase in revenues is primarily due to changes in the number and size of active customer contracts and the level of effort performed on each one during the periods. Revenue in the current reporting period is derived from professional services provided to multiple government and commercial customers under multi-month contracts.

 

Cost of Revenues

 

Cost of revenues for the nine months ended September 30, 2023 was $131,117 compared to $41,692 for the comparable prior year period, an increase of $89,425 or 214%. The increase in cost of revenues is primarily due to the increase in direct labor expense required to perform on the contracts in the current quarter compared to the prior year period. Cost of revenues for the current reporting period consists primarily of salary expense.

 

Gross Profit/Gross Margin

 

Gross profit and gross margin for the nine months ended September 30, 2023 was $152,037 and 54%, respectively, compared to $92,678 and 69%, respectively, for the comparable prior year period, an increase of $59,359. The increase in gross profit is primarily due to the increase in gross revenue during the nine months ended September 30, 2023 compared to the prior year period, and the decrease in gross margin is primarily due to the increase in the amount of direct labor required to perform the contracted services in the current period.

 

Operating Expenses

 

Operating expenses for the nine months ended September 30, 2023 were $19,466,158 compared to $18,443,966 for the comparable prior year period, an increase of $1,022,192 or 6%. The increase in operating expenses compared to the comparable prior year period is due in large part to the $1,676,187 increase in research and development expenses for additional technical labor, parts and supplies needed to design and test new hardware products and the net $892,433 increase in combined stock-based compensation and salary expenses, offset by the $1,227,307 decrease in other SG&A costs driven by reductions in legal expenses and adjustments in intangibles related to the QPhoton merger, and the $319,121 decrease in consultant and professional services expense driven in large part by an increasing use of full and part time employees.

 

8

 

 

Net Loss

 

Our net loss for the nine months ended September 30, 2023 was $21,424,504 compared to a net loss of $19,807,546 for the comparable prior year period, an increase of $1,616,958 or 8%. The increase in net loss is primarily due to the changes in operating expenses discussed above, and the increased financing costs for the ATM facility that we began using in January 2023 and for the Streeterville Note that we issued in September 2022.

 

Liquidity and Capital Resources

 

We have incurred net losses and experienced negative cash flows from operations since inception. To date, since February 2018, the Company has raised $51,229,464 through private and public placements of equity and $12,633,000 through private placements of convertible promissory notes and other debt for a total of $63,862,464 through September 30, 2023. The Company has no lines of credit and $4,546,843 in short-term debt obligations outstanding. We expect to incur additional losses and higher operating expenses for the foreseeable future as we continue to invest in research and development and go-to-market programs. We have determined that additional financing will be required to fund our operations for the next 12 months and our ability to continue as a going concern is dependent upon obtaining additional capital and financing. As of September 30, 2023, the Company had cash and cash equivalents of $7,379,362.

 

Our primary uses of cash are to fund our operations as we continue to grow our business. We will require a significant amount of cash for expenditures as we invest in ongoing research and development and Quantum Optical Chips and fund business operations. Until such time as we can generate significant revenue from sales or subscriptions of our hardware and our Quantum Solutions offerings, we expect to finance our cash needs through public and/or private equity and/or debt financings or other capital sources, including but not limited to U.S. government grant and loan programs. However, we may be unable to raise sufficient funds or enter into such other arrangements, when needed, on favorable terms, or at all. In particular, uncertain and unfavorable conditions in the United States and global macroeconomic environment, including inflationary pressures, rising interest rates, banking collapses, and financial and credit market fluctuations, could reduce our ability to access capital on favorable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be, or could be, diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, or substantially reduce our quantum computing development and go-to-market efforts.

 

The following table summarizes total current assets, liabilities and working capital at September 30, 2023, compared to December 31, 2022:

 

   September 30,
2023
   December 31,
2022
   Increase (Decrease) 
Current Assets  $8,109,515   $5,587,647   $2,521,868 
Current Liabilities  $8,088,926   $6,545,320   $1,543,606 
Working Capital (Deficit)  $20,589   $(957,673)  $978,262 

 

At September 30, 2023, the Company had working capital of $20,589 compared to a working capital deficit of $957,673 at December 31, 2022. The $978,262 increase in working capital is primarily due to additional cash of $2,070,896 obtained from net proceeds from sales of our common stock under the ATM facility during the current period, offset by the remaining principal of the Streeterville Note becoming a current liability and reductions to accrued expenses.

 

Cash Flows

 

Net cash used in operating activities for the nine months ended September 30, 2023 and 2022 was $14,635,011 and $11,565,125, respectively, in each case primarily as a result of our net loss in each period offset by noncash adjustments for stock based compensation.

 

Net cash used in investing activities for the nine months ended September 30, 2023 and 2022 was $2,733,374 and $1,478,281, respectively. Net cash used in investment activities related primarily to our purchase of $2,164,600 of computer hardware and laboratory equipment and our $500,000 investment in MW Notes during the nine months ended September 30, 2023. For the period ended September 30, 2022, net cash used in investment activities was almost entirely attributable to our merger with QPhoton in September 2022.

 

Net cash provided by financing activities was $19,439,281 and $8,361,290 for the nine months ended September 30, 2023 and 2022, respectively. Cash flows provided by financing activities during the nine months ended September 30, 2023 were attributable to use of the ATM facility to sell shares of our common stock, offset by repayments on the Streeterville Note. The cash provided by financing activities during the period ended September 30, 2022 was attributable to the issuance of the Streeterville Note and amortization of the original issue discount for the outstanding shares of our Series A Convertible Preferred stock.

 

9

 

 

During the first nine months of 2023, we have funded our operations primarily through the sale of shares of our common stock and the use of cash on hand. As of November 10, 2023, we had cash on hand of approximately $3.6 million We have approximately $96,921 in monthly lease and other mandatory payments, not including payroll, employee benefits and ordinary expenses that are due monthly.

 

On a long-term basis, our liquidity is dependent on continuation and expansion of operations and receipt of revenues. Demand for the products and services will be dependent on, among other things, market acceptance of our products and services, the technology market in general, and general economic conditions, which are cyclical in nature.

 

Critical Accounting Estimates

 

Certain of our accounting policies require the application of significant judgment by our management, and such judgments are reflected in the amounts reported in our condensed consolidated financial statements. In applying these policies, our management uses judgment to determine the appropriate assumptions to be used in the determination of estimates. Those estimates are based on our historical experience, terms of existing contracts, our observance of market trends, information provided by our strategic partners and information available from other outside sources, as appropriate. Actual results may differ significantly from the estimates contained in our condensed consolidated financial statements.

 

Revenue

 

The Company recognizes revenue in accordance with ASC 606 – Revenue from Contracts with Customers. We recognize revenue from time and materials-based contracts as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost reimbursement (“cost-plus”) type contracts at this time.

 

Legal and Other Contingencies

 

The outcomes of legal proceedings and claims brought against us are subject to significant uncertainty. An estimated loss from a loss contingency such as a legal proceeding or claim is accrued by a charge to income if it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. In determining whether a loss should be accrued we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our consolidated financial statements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls and procedures. Based on such evaluation, our principal executive officer and principal financial officer concluded that as of September 30, 2023, our disclosure controls and procedures were not effective to provide reasonable assurance that (a) the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (b) such information is accumulated and communicated to our management, including our Chief Executive Officer and President and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Specifically, the Company does not have sufficient accounting staff to enable proper segregation of duties.

 

(b) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

10

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Except as listed below, there is no action, suit, or proceeding by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or our subsidiaries, threatened against or affecting the Company, our common stock, our subsidiaries or the Company’s or its subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect on the Company.

 

BV Advisory Partners, LLC (“BV Advisory”) was purportedly a shareholder of QPhoton, the predecessor in interest to QPhoton, LLC, a wholly-owned subsidiary of the Company (both referred to as “QPhoton” in this Legal Proceedings discussion). On October 13, 2022, BV Advisory filed a petition in the Court of Chancery of the State of Delaware seeking appraisal rights on the shares of common stock of QPhoton it allegedly owns (which shares represented 10% of the shares of common stock of QPhoton outstanding immediately prior to the Company’s acquisition of QPhoton) pursuant to Section 262 of the General Corporation Law of the State of Delaware. The parties are currently engaged in discovery and the Company does not have sufficient information to assess the potential impact of the appraisal demand at this time.

 

In addition, on March 1, 2021, QPhoton entered into a Note Purchase Agreement with BV Advisory. Under the Note Purchase Agreement, on March 1, 2021, March 23, 2021 and July 9, 2021, QPhoton and BV Advisory entered into convertible promissory notes for $200,592, $150,000, and $150,000, respectively, for a total of $500,592 (the “BV Notes”). The BV Notes all bore interest at a rate of 6% per annum and matured two years from the grant date.

 

On June 16, 2022, the effective date of our acquisition of QPhoton, QPhoton tendered a cashier’s check to BV Advisory in the amount of $535,68.44, representing the full principal balance of the BV Notes and accrued interest through June 16, 2022. BV subsequently filed suit against the Company disputing the calculation of the payment amount and asserting other claims.

 

On August 15, 2022, BV Advisory filed a complaint in the Court of Chancery of the State of Delaware naming the Company and certain of its directors and officers (among others) as defendants (the “Lawsuit”). BV Advisory is seeking, among other relief, monetary damages for an alleged breach of the Note Purchase Agreement between BV Advisory and QPhoton, as well as monetary damages for alleged breach of an alleged binding letter of intent among Barksdale Global Holdings, LLC (“BGH”), Inference Ventures, LLC (“Inference Ventures”) and QPhoton. BV Advisory and its affiliates claim, pursuant to the letter of intent, that they had the right to acquire additional shares in QPhoton thereunder by investing $2.5 million in QPhoton. BV Advisory claims QPhoton refused to allow BV Advisory to purchase the equity, however, BV Advisory never made the additional investment in QPhoton. The Company believes that BV Advisory’s claims have no merit and intends to defend itself vigorously. Moreover, the Company believes that numerous alleged facts and characterizations set forth in BV Advisory’s complaint are false, misleading and intentionally designed to damage the Company’s reputation, and the Company categorically rejects those alleged facts and characterizations. The Company further believes that Mr. Barksdale misrepresented his role with QPhoton and his authority to negotiate on behalf of QPhoton in order to arrogate to BV Advisory and related parties a larger share of the QPhoton merger consideration. The Company has filed a motion to dismiss the Lawsuit, and oral arguments were held in October 2023. The Company’s motion to dismiss is currently under consideration by the court.

 

On December 30, 2022 the Company, QPhoton and Robert Liscouski (the “Quantum Plaintiffs”) filed suit in the Superior Court of New Jersey against Keith Barksdale, Michael Kotlarz, BV Advisory, BGH, Power Analytics Global Corporation (“PAG”), and Inference Ventures (and together with Barksdale, Kotlarz, BV Advisory, BGH, and PAG the “BV Defendants”), alleging fraud, aiding and abetting fraud, defamation, and conspiracy to defraud, seeking monetary and injunctive relief. The Company claims that the BV Defendants have made numerous public statements defaming the Company and its management in furtherance of a plan to manipulate the trading prices of the Company’s common stock, and that the BV Defendants misrepresented their ownership in QPhoton and conspired to acquire additional shares of QPhoton at the Company’s expense. The BV Defendants filed a motion to dismiss the complaint on March 24, 2023, and the Quantum Plaintiffs filed a brief in opposition to that motion. On June 5, 2023, the Court largely denied the BV Defendants’ motion and issued an order dismissing in part one claim and dismissing QPhoton as a plaintiff, but leaving in place the majority of the claims against the BV Defendants. On July 27, 2023, the BV Defendants answered the complaint and asserted counter claims against the Quantum Plaintiffs, and third-party claims against Stevens Institute (which held nine percent (9%) of QPhoton at the time of the QPhoton merger), alleging that the assignment of the Stevens Institute patent license from QPhoton to the Company upon the closing of the QPhoton merger violated the terms of the BV Note Purchase Agreement and was a fraudulent transfer that damaged the BV Defendants and QPhoton and in which Stevens was complicit. Dr. Yuping Huang, founder of QPhoton, has been a professor at the Stevens Institute since 2014 and is the founding director of the Center for Quantum Science and Engineering at Stevens Institute. In December 2020, QPhoton licensed seven patents from Stevens Institute for technologies invented by Dr. Huang and his research team. On August 31, 2023, the Quantum Plaintiffs filed a motion to amend the complaint, seeking declaratory judgement that BV Advisory failed to pay the agreed purchase price and therefore did not properly acquire its alleged shares of QPhoton and for injunctive relief against ongoing defamation by the BV Defendants. On September 6, 2023, BV Advisory filed a motion to transfer the case to the NJ Complex Business Litigation track and on September 14, 2023 filed a brief in opposition to the Quantum Plaintiff’s motion to amend the complaint. On September 29, 2023, the NJ Superior Court transferred the case to the Complex Litigation track and requested that all motions be withdrawn without prejudice, pending a judicial conference that is scheduled for November 15, 2023. The Company does not have sufficient information at this time to assess the potential impact of the action against the BV Defendants.

 

11

 

 

On July 27, 2023, BV Advisory and its managing member, Keith Barksdale, as alleged stockholders of and claimants against the Company, filed a petition in the Court of Chancery of the State of Delaware to appoint a receiver for the Company based on allegations that the Company is insolvent due to purported poor corporate governance and cash management. The petition also objects to the Company’s approach to raising capital. In a related motion, the petitioners also sought expedited treatment of the petition on July 28, 2023 under the presumption that they allegedly face a threat of irreparable harm. The Company strongly disagrees with the allegations in the Petition and considers these claims baseless and without merit. On August 8, 2023, the Company filed a motion to dismiss the petition and submitted a brief in opposition to the motion to expedite. The Company intends to vigorously defend itself against the allegations in the Petition. The Company’s motion to dismiss and BV Advisory’s motion for expedited treatment were argued before the Court on October 11, 2023. The Court denied BV Advisory’s motion to expedite and took the Company’s motion to dismiss under advisement.

 

Item 1A. Risk Factors

 

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 29, 2023.

 

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Repurchases of Equity Securities

 

There were no unregistered sales of the Company’s equity securities during the quarter ended September 30, 2023.

 

Item 3. Defaults upon Senior Securities

 

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

        Incorporated by    
Exhibit       Reference   Filed or Furnished
Number   Exhibit Description   Form   Exhibit   Filing Date   Herewith
10.1   First Amendment to ATM Agreement, dated as of August 17, 2023, between Quantum Computing Inc. and Ascendiant Capital Markets, LLC   8-K   1.1  

08/21/2023

   
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.               X
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.               X
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350.               X
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350.               X
101.INS   Inline XBRL Instance Document               X
101.SCH   Inline XBRL Taxonomy Extension Schema Linkbase Document.               X
101.CAL   Inline XBRL Taxonomy Calculation Linkbase Document.               X
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.               X
101.LAB   Inline XBRL Taxonomy Label Linkbase Document.               X
101.PRE   Inline XBRL Taxonomy Presentation Linkbase Document.               X
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).                

 

**Indicates a management contract or compensatory plan or arrangement.

 

12

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  QUANTUM COMPUTING INC.
     
Dated: November 13, 2023 By: /s/ Robert Liscouski
    Robert Liscouski
    Principal Executive Officer
     
  By: /s/ Christopher Boehmler
    Christopher Boehmler
    Principal Financial Officer and
Principal Accounting Officer

 

 

13

 

 

75094943 75094943 53568.44 false --12-31 Q3 0001758009 0001758009 2023-01-01 2023-09-30 0001758009 2023-11-10 0001758009 2023-09-30 0001758009 2022-12-31 0001758009 us-gaap:SeriesAPreferredStockMember 2023-09-30 0001758009 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001758009 us-gaap:SeriesBPreferredStockMember 2023-09-30 0001758009 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001758009 2022-01-01 2022-09-30 0001758009 2023-07-01 2023-09-30 0001758009 2022-07-01 2022-09-30 0001758009 us-gaap:PreferredStockMember 2021-12-31 0001758009 us-gaap:CommonStockMember 2021-12-31 0001758009 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001758009 us-gaap:RetainedEarningsMember 2021-12-31 0001758009 2021-12-31 0001758009 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001758009 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001758009 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001758009 2022-01-01 2022-03-31 0001758009 us-gaap:PreferredStockMember 2022-03-31 0001758009 us-gaap:CommonStockMember 2022-03-31 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001758009 us-gaap:RetainedEarningsMember 2022-03-31 0001758009 2022-03-31 0001758009 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001758009 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001758009 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001758009 2022-04-01 2022-06-30 0001758009 us-gaap:PreferredStockMember 2022-06-30 0001758009 us-gaap:CommonStockMember 2022-06-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001758009 us-gaap:RetainedEarningsMember 2022-06-30 0001758009 2022-06-30 0001758009 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001758009 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001758009 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001758009 us-gaap:PreferredStockMember 2022-09-30 0001758009 us-gaap:CommonStockMember 2022-09-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001758009 us-gaap:RetainedEarningsMember 2022-09-30 0001758009 2022-09-30 0001758009 us-gaap:PreferredStockMember 2022-12-31 0001758009 us-gaap:CommonStockMember 2022-12-31 0001758009 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001758009 us-gaap:RetainedEarningsMember 2022-12-31 0001758009 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001758009 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001758009 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001758009 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001758009 2023-01-01 2023-03-31 0001758009 us-gaap:PreferredStockMember 2023-03-31 0001758009 us-gaap:CommonStockMember 2023-03-31 0001758009 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001758009 us-gaap:RetainedEarningsMember 2023-03-31 0001758009 2023-03-31 0001758009 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001758009 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001758009 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001758009 2023-04-01 2023-06-30 0001758009 us-gaap:PreferredStockMember 2023-06-30 0001758009 us-gaap:CommonStockMember 2023-06-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001758009 us-gaap:RetainedEarningsMember 2023-06-30 0001758009 2023-06-30 0001758009 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001758009 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001758009 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001758009 us-gaap:PreferredStockMember 2023-09-30 0001758009 us-gaap:CommonStockMember 2023-09-30 0001758009 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001758009 us-gaap:RetainedEarningsMember 2023-09-30 0001758009 qubt:CorporateHistoryMember 2018-07-20 0001758009 qubt:ATMAgreementMember srt:MinimumMember 2023-08-17 0001758009 qubt:ATMAgreementMember srt:MaximumMember 2023-08-17 0001758009 us-gaap:CommonStockMember 2023-08-17 0001758009 qubt:TwoThousandTwentyTwoShelfMember 2023-09-30 0001758009 qubt:ATMAgreementMember 2023-09-30 0001758009 qubt:ConsolidationMember 2023-01-01 2023-09-30 0001758009 qubt:ConsolidationMember 2023-09-30 0001758009 qubt:MorganStanleyMember 2023-09-30 0001758009 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-09-30 0001758009 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-09-30 0001758009 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001758009 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001758009 qubt:MergerWithQPhotonIncMember 2023-09-30 0001758009 qubt:MergerWithQPhotonIncMember us-gaap:SeriesBPreferredStockMember 2023-09-30 0001758009 us-gaap:WarrantMember 2023-09-30 0001758009 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-09-30 0001758009 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-06-16 0001758009 us-gaap:CustomerRelationshipsMember 2023-09-30 0001758009 qubt:NonCompeteAgreementMember 2023-01-01 2023-09-30 0001758009 qubt:NonCompeteAgreementMember 2023-09-30 0001758009 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-09-30 0001758009 us-gaap:TrademarksAndTradeNamesMember 2023-09-30 0001758009 us-gaap:PatentedTechnologyMember 2023-01-01 2023-09-30 0001758009 us-gaap:PatentedTechnologyMember 2023-09-30 0001758009 us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember 2023-09-30 0001758009 us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember 2023-01-01 2023-09-30 0001758009 2022-06-30 2022-06-30 0001758009 qubt:QPhotonMember 2022-02-18 0001758009 qubt:QPhotonMember 2022-02-18 0001758009 2022-04-01 0001758009 2022-04-01 2022-04-01 0001758009 2022-02-18 0001758009 2023-03-01 0001758009 us-gaap:CustomerRelationshipsMember qubt:InitialValuationEstimateMember 2023-06-30 0001758009 us-gaap:CustomerRelationshipsMember qubt:FinalValuationMember 2023-04-01 2023-06-30 0001758009 us-gaap:CustomerRelationshipsMember qubt:IncreaseDecreaseIntangibleAssetsMember 2023-04-01 2023-06-30 0001758009 qubt:NoncompeteAgreementWithFounderMember qubt:InitialValuationEstimateMember 2023-06-30 0001758009 qubt:NoncompeteAgreementWithFounderMember qubt:FinalValuationMember 2023-04-01 2023-06-30 0001758009 qubt:NoncompeteAgreementWithFounderMember qubt:IncreaseDecreaseIntangibleAssetsMember 2023-04-01 2023-06-30 0001758009 us-gaap:TrademarksAndTradeNamesMember qubt:InitialValuationEstimateMember 2023-06-30 0001758009 us-gaap:TrademarksAndTradeNamesMember qubt:FinalValuationMember 2023-04-01 2023-06-30 0001758009 us-gaap:TrademarksAndTradeNamesMember qubt:IncreaseDecreaseIntangibleAssetsMember 2023-04-01 2023-06-30 0001758009 qubt:EmploymentAgreementsMember qubt:InitialValuationEstimateMember 2023-06-30 0001758009 qubt:EmploymentAgreementsMember qubt:FinalValuationMember 2023-04-01 2023-06-30 0001758009 qubt:EmploymentAgreementsMember qubt:IncreaseDecreaseIntangibleAssetsMember 2023-04-01 2023-06-30 0001758009 qubt:TechnologyAndLicensedPatentsMember qubt:InitialValuationEstimateMember 2023-06-30 0001758009 qubt:TechnologyAndLicensedPatentsMember qubt:FinalValuationMember 2023-04-01 2023-06-30 0001758009 qubt:TechnologyAndLicensedPatentsMember qubt:IncreaseDecreaseIntangibleAssetsMember 2023-04-01 2023-06-30 0001758009 qubt:InitialValuationEstimateMember 2023-06-30 0001758009 qubt:FinalValuationMember 2023-04-01 2023-06-30 0001758009 qubt:IncreaseDecreaseIntangibleAssetsMember 2023-04-01 2023-06-30 0001758009 us-gaap:GoodwillMember 2023-09-30 0001758009 us-gaap:GoodwillMember 2022-12-31 0001758009 2023-01-01 2023-06-30 0001758009 us-gaap:CustomerRelationshipsMember 2022-12-31 0001758009 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-09-30 0001758009 qubt:NoncompeteAgreementWithFounderMember 2023-09-30 0001758009 qubt:NoncompeteAgreementWithFounderMember 2022-12-31 0001758009 qubt:NoncompeteAgreementWithFounderMember 2023-01-01 2023-09-30 0001758009 us-gaap:TrademarksAndTradeNamesMember 2023-09-30 0001758009 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001758009 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-09-30 0001758009 qubt:EmploymentAgreementsMember 2023-09-30 0001758009 qubt:EmploymentAgreementsMember 2022-12-31 0001758009 qubt:EmploymentAgreementsMember 2023-01-01 2023-09-30 0001758009 qubt:TechnologyAndLicensedPatentsMember 2023-09-30 0001758009 qubt:TechnologyAndLicensedPatentsMember 2022-12-31 0001758009 qubt:TechnologyAndLicensedPatentsMember 2023-01-01 2023-09-30 0001758009 2022-01-01 2022-12-31 0001758009 qubt:HardwareAndEquipmentMember 2023-09-30 0001758009 qubt:HardwareAndEquipmentMember 2022-12-31 0001758009 us-gaap:SoftwareDevelopmentMember 2023-09-30 0001758009 us-gaap:SoftwareDevelopmentMember 2022-12-31 0001758009 us-gaap:ComputerEquipmentMember 2023-09-30 0001758009 us-gaap:TechnologyEquipmentMember 2023-09-30 0001758009 us-gaap:EquipmentMember 2023-09-30 0001758009 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001758009 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001758009 2021-03-01 0001758009 2021-03-23 0001758009 2021-07-09 0001758009 qubt:BVAdvisoryPartnersLLCMember 2023-09-30 0001758009 qubt:BVAdvisoryPartnersLLCMember 2023-01-01 2023-09-30 0001758009 2022-06-16 0001758009 2022-09-23 0001758009 qubt:millionwaysMember 2023-05-16 0001758009 2023-05-16 0001758009 2023-06-06 0001758009 srt:MinimumMember 2023-06-06 0001758009 srt:MaximumMember 2023-06-06 0001758009 us-gaap:SeriesAPreferredStockMember 2021-11-10 2021-11-17 0001758009 us-gaap:SeriesAPreferredStockMember 2021-11-17 0001758009 qubt:FalconCapitalPartnersMember us-gaap:SeriesAPreferredStockMember 2022-06-13 0001758009 qubt:FalconCapitalPartnersMember us-gaap:SeriesAPreferredStockMember 2022-06-13 2022-06-13 0001758009 qubt:GreenfieldChildrenLLCMember us-gaap:SeriesAPreferredStockMember 2023-02-06 2023-02-09 0001758009 qubt:DraperIncMember 2023-01-20 0001758009 qubt:CarriageHouseCapitalIncMember 2023-01-20 0001758009 2023-05-03 0001758009 qubt:AscendiantCapitalMember 2023-09-30 0001758009 qubt:AscendiantCapitalMember 2023-01-01 2023-09-30 0001758009 2022-10-11 0001758009 qubt:Options2019Member 2023-09-30 0001758009 2022-07-05 0001758009 us-gaap:CommonStockMember 2023-01-01 0001758009 qubt:Options2022Member 2023-09-30 0001758009 2020-08-01 2020-08-31 0001758009 2021-11-01 2021-11-30 0001758009 2022-06-01 2022-06-16 0001758009 srt:MinimumMember 2023-01-01 2023-09-30 0001758009 srt:MaximumMember 2023-01-01 2023-09-30 0001758009 srt:MinimumMember 2022-01-01 2022-12-31 0001758009 srt:MaximumMember 2022-01-01 2022-12-31 0001758009 qubt:ExercisePrice100Member 2023-09-30 0001758009 qubt:ExercisePrice135Member 2023-09-30 0001758009 qubt:ExercisePrice145Member 2023-09-30 0001758009 qubt:ExercisePrice167Member 2023-09-30 0001758009 qubt:ExercisePrice184Member 2023-09-30 0001758009 qubt:ExercisePrice195Member 2023-09-30 0001758009 qubt:ExercisePrice237Member 2023-09-30 0001758009 qubt:ExercisePrice240Member 2023-09-30 0001758009 qubt:ExercisePrice256Member 2023-09-30 0001758009 qubt:ExercisePrice261Member 2023-09-30 0001758009 qubt:ExercisePrice358Member 2023-09-30 0001758009 qubt:ExercisePrice398Member 2023-09-30 0001758009 qubt:ExercisePrice569Member 2023-09-30 0001758009 qubt:ExercisePrice570Member 2023-09-30 0001758009 qubt:ExercisePrice649Member 2023-09-30 0001758009 qubt:ExercisePrice685Member 2023-09-30 0001758009 qubt:ExercisePrice700Member 2023-09-30 0001758009 qubt:ExercisePrice755Member 2023-09-30 0001758009 qubt:ExercisePrice885Member 2023-09-30 0001758009 qubt:ExercisePrice1000Member 2023-09-30 0001758009 qubt:ExercisePrice1151Member 2023-09-30 0001758009 qubt:ExercisePrice1165Member 2023-09-30 0001758009 qubt:ExercisePrice200Member 2023-01-01 2023-09-30 0001758009 qubt:ExercisePrice700Member 2023-01-01 2023-09-30 0001758009 qubt:ExercisePrice00001Member 2023-01-01 2023-09-30 0001758009 us-gaap:SubsequentEventMember 2023-10-01 2023-10-03 0001758009 srt:MinimumMember us-gaap:SubsequentEventMember 2023-10-01 2023-10-31 0001758009 srt:MaximumMember us-gaap:SubsequentEventMember 2023-10-01 2023-10-31 0001758009 qubt:StreetervilleMember us-gaap:SubsequentEventMember 2023-10-01 2023-11-10 0001758009 qubt:StreetervilleMember us-gaap:SubsequentEventMember 2023-11-10 0001758009 us-gaap:SubsequentEventMember 2023-11-10 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

 

I, Robert Liscouski, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Quantum Computing Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2023  
   
/s/ Robert Liscouski  
Robert Liscouski  
Chief Executive Officer  

Exhibit 31.2

 

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

 

I, Christopher Boehmler, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Quantum Computing Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2023  
   
/s/ Christopher Boehmler  
Christopher Boehmler  
Principal Accounting Officer  

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

CERTIFICATION

 

In connection with the Quarterly Report of Quantum Computing Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert Liscouski, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Robert Liscouski  
Robert Liscouski  
Chief Executive Officer  
   
November 13, 2023  

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

CERTIFICATION

 

In connection with the Quarterly Report of Quantum Computing Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Roberts, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Christopher Boehmler  
Christopher Boehmler  
Principal Accounting Officer  
   
November 13, 2023  

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 10, 2023
Document Information Line Items    
Entity Registrant Name QUANTUM COMPUTING INC.  
Trading Symbol QUBT  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   75,097,249
Amendment Flag false  
Entity Central Index Key 0001758009  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-40615  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 82-4533053  
Entity Address, Address Line One 215 Depot Court SE,  
Entity Address, Address Line Two Suite 215  
Entity Address, City or Town Leesburg  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 20175  
City Area Code (703)  
Local Phone Number 436-2121  
Title of 12(b) Security Common Stock, par value $.0001  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
v3.23.3
Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 7,379,362 $ 5,308,466
Accounts receivable 2,435 12,774
Prepaid expenses 167,201 224,302
Loans receivable 543,178
Other current assets 17,339 42,105
Subtotal current assets 8,109,515 5,587,647
Fixed assets (net of depreciation) 2,958,287 975,169
Other Assets    
Lease right of use 1,115,397 1,327,746
Security deposits 129,045 60,271
Intangible Assets-net of amortization 12,099,013 22,223,725
Goodwill 64,921,294 59,125,773
Subtotal Other Assets 78,264,749 82,737,515
Total assets 89,332,551 89,300,331
Current liabilities    
Accounts payable 1,130,739 871,887
Accrued expenses 1,030,357 3,559,981
Deferred Revenue 12,000
Lease liability 1,153,868 1,357,924
Dividends payable - preferred 215,119 219,844
Loans payable – short term 4,512,718 535,684
Accrued interest – short term 34,125
Current liabilities – subtotal 8,088,926 6,545,320
Long term liabilities    
Loans payable – long term 7,632,998
Accrued Interest – long term 225,282
Long term liabilities – subtotal 7,858,280
Total liabilities 8,088,926 14,403,600
Stockholders’ equity    
Preferred stock, $0.0001 par value, 1,550,000 shares Series A Convertible Preferred authorized; 1,490,004 and 1,500,004 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively; 3,079,864 shares of Series B Preferred Stock authorized, 0 and 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 149 150
Common stock, $0.0001 par value, 250,000,000 shares authorized; 75,094,943and 55,963,334 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 7,510 5,596
Additional paid-in capital 170,479,502 151,163,909
APIC-Beneficial Conversion Feature in Equity 4,898,835 4,898,835
APIC-Stock Based Compensation 47,269,914 38,816,022
Accumulated deficit (141,412,285) (119,987,781)
Total stockholders’ equity 81,243,625 74,896,731
Total liabilities and stockholders’ equity $ 89,332,551 $ 89,300,331
v3.23.3
Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 75,094,943 55,963,334
Common stock, shares outstanding 75,094,943 55,963,334
Series A Convertible Preferred Stock    
Preferred stock par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,550,000 1,550,000
Preferred stock, shares issued 1,490,004 1,500,004
Preferred stock, shares outstanding 1,490,004 1,500,004
Series B Convertible Preferred Stock    
Preferred stock, shares authorized 3,079,864 3,079,864
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
v3.23.3
Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Total revenue $ 50,435 $ 37,646 $ 283,154 $ 134,370
Cost of revenue 23,721 24,891 131,117 41,692
Gross profit 26,714 12,755 152,037 92,678
Salaries and Benefits 1,456,770 1,299,587 3,441,092 3,776,324
Consulting 196,178 297,107 604,499 923,620
Research & Development 1,698,399 1,266,489 4,817,707 3,141,520
Stock Based Compensation 1,977,671 1,261,969 5,893,296 4,665,631
Selling General & Administrative 2,365,213 2,721,596 4,709,564 5,936,871
Operating expenses 7,694,231 6,846,748 19,466,158 18,443,966
Loss from Operations (7,667,517) (6,833,993) (19,314,121) (18,351,288)
Other Income and Expense        
Interest Income 125,718 1,160 218,698 45,187
Interest Expense – Promissory Notes 128,419 18,320 528,564 18,320
Interest Expense – Preferred dividends 215,119 223,125 645,952 669,375
Interest Expense – Financing expenses 390,582 495,000 1,154,565 813,750
Net Other income (expense) (608,402) (735,285) (2,110,383) (1,456,258)
Income tax expense
Net loss $ (8,275,919) $ (7,569,278) $ (21,424,504) $ (19,807,546)
Weighted average shares – basic (in Shares) 75,094,943 33,904,329 75,094,943 33,904,329
Weighted average shares – diluted (in Shares) 96,646,401 68,903,577 96,646,401 68,903,577
Loss per share – basic (in Dollars per share) $ (0.11) $ (0.22) $ (0.29) $ (0.58)
Loss per share – diluted (in Dollars per share) $ (0.09) $ (0.11) $ (0.22) $ (0.29)
v3.23.3
Consolidated Statement of Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2021 $ 154 $ 2,916 $ 97,592,909 $ (81,394,081) $ 16,201,898
Balances (in Shares) at Dec. 31, 2021 1,545,459 29,156,815      
Issuance of shares for cash
Issuance of shares for services
Preferred OID Amortization 212,500 212,500
Stock Options 2,985,453 2,985,453
Stock based compensation
Net loss (7,133,692) (7,133,692)
Balances at Mar. 31, 2022 $ 154 $ 2,916 100,790,862 (88,527,773) 12,266,159
Balances (in Shares) at Mar. 31, 2022 1,545,459 29,156,815      
Balances at Dec. 31, 2021 $ 154 $ 2,916 97,592,909 (81,394,081) 16,201,898
Balances (in Shares) at Dec. 31, 2021 1,545,459 29,156,815      
Net loss         (19,807,546)
Balances at Sep. 30, 2022 $ 343 $ 3,390 185,377,443 (101,201,627) $ 84,179,549
Balances (in Shares) at Sep. 30, 2022 3,425,396 33,904,329     33,904,329
Balances at Mar. 31, 2022 $ 154 $ 2,916 100,790,862 (88,527,773) $ 12,266,159
Balances (in Shares) at Mar. 31, 2022 1,545,459 29,156,815      
Issuance of shares for cash
Conversion of Preferred $ (4) $ 4
Conversion of Preferred (in Shares) (45,455) 47,728      
Merger consideration 83,083,867 83,083,867
Derivatives & Warrants
Preferred OID Amortization 106,250 106,250
Stock Options 229,510 229,510
Stock based compensation
Net loss (5,104,576) (5,104,576)
Balances at Jun. 30, 2022 $ 150 $ 2,920 184,210,489 (93,632,349) 90,581,210
Balances (in Shares) at Jun. 30, 2022 1,500,004 29,204,543      
Issuance of shares for cash
Conversion of Preferred
Merger consideration $ 193 $ 470 (663)
Merger consideration (in Shares) 1,925,392 4,699,786      
Derivatives & Warrants
Preferred OID Amortization
Stock Options 1,167,617 1,167,617
Stock based compensation
Net loss 0 (7,569,278) (7,569,278)
Balances at Sep. 30, 2022 $ 343 $ 3,390 185,377,443 (101,201,627) $ 84,179,549
Balances (in Shares) at Sep. 30, 2022 3,425,396 33,904,329     33,904,329
Balances at Dec. 31, 2022 $ 150 $ 5,596 194,878,766 (119,987,781) $ 74,896,731
Balances (in Shares) at Dec. 31, 2022 1,500,004 55,963,334      
Issuance of shares for cash $ 302 6,551,153 6,551,455
Issuance of shares for cash (in Shares) 3,021,632      
Conversion of Preferred $ (1) $ 1 596 596
Conversion of Preferred (in Shares) (10,000) 11,096      
Merger consideration
Issuance of shares for services $ 150 2,324,850 2,325,000
Issuance of shares for services (in Shares) 1,500,000      
Stock Options 1,675,707 1,675,707
Net loss (8,506,137) (8,506,137)
Balances at Mar. 31, 2023 $ 149 $ 6,049 205,431,072 (128,493,918) 76,943,352
Balances (in Shares) at Mar. 31, 2023 1,490,004 60,496,062      
Balances at Dec. 31, 2022 $ 150 $ 5,596 194,878,766 (119,987,781) 74,896,731
Balances (in Shares) at Dec. 31, 2022 1,500,004 55,963,334      
Net loss         (21,424,504)
Balances at Sep. 30, 2023 $ 149 $ 7,510 222,648,251 (141,412,285) $ 81,243,625
Balances (in Shares) at Sep. 30, 2023 1,490,004 75,094,943     75,094,943
Balances at Mar. 31, 2023 $ 149 $ 6,049 205,431,072 (128,493,918) $ 76,943,352
Balances (in Shares) at Mar. 31, 2023 1,490,004 60,496,062      
Issuance of shares for cash $ 589 8,116,047 8,116,636
Issuance of shares for cash (in Shares) 5,889,097      
Conversion of Preferred
Merger consideration (3,600,315) (3,600,315)
Issuance of shares for services
Stock Options 2,030,277 2,030,277
Stock based compensation $ 85 (1,935,051) (1,934,966)
Stock based compensation (in Shares) 853,600      
Net loss (4,642,448) (4,642,448)
Balances at Jun. 30, 2023 $ 149 $ 6,724 210,042,030 (133,136,366) 76,912,537
Balances (in Shares) at Jun. 30, 2023 1,490,004 67,238,759      
Issuance of shares for cash $ 638 8,800,831 8,801,469
Issuance of shares for cash (in Shares) 6,379,784      
Conversion of Preferred
Merger consideration 185,384 185,384
Issuance of shares for services
Stock Options 1,993,769 1,993,769
Stock based compensation $ 148 1,997,005 1,997,154
Stock based compensation (in Shares) 1,476,400      
Net loss (8,275,919) (8,275,919)
Balances at Sep. 30, 2023 $ 149 $ 7,510 $ 222,648,251 $ (141,412,285) $ 81,243,625
Balances (in Shares) at Sep. 30, 2023 1,490,004 75,094,943     75,094,943
v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (21,424,504) $ (19,807,546)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation 181,483 21,551
Amortization of intangibles 543,492 1,749,190
Stock based compensation 8,086,939 4,382,581
Debt discount 374,314
Changes in operating assets and liabilities (net of amounts acquired)    
Accounts receivable 10,338 (94,807)
Prepaid expenses 57,104 180,381
Deferred revenue 12,000
Other Assets (43,178)  
Accounts payable 283,618 234,791
Accrued expenses (2,720,781) 6,727
Dividends payable (4,129) 105,671
Operating lease liability 8,293 (18,829)
CASH USED IN OPERATING ACTIVITIES (14,635,011) (13,240,290)
CASH FLOWS FROM INVESTING ACTIVITIES    
Property and equipment (2,164,600) (166,206)
Security deposits (68,774) 41,344
Loans receivable (500,000)
Other current assets 2,652
Net cash used for QPhoton, Inc. merger (1,356,071)
CASH USED IN INVESTING ACTIVITIES (2,733,374) (1,478,281)
CASH FLOWS FROM FINANCING ACTIVITIES    
Notes payable (4,030,279) 8,042,540
Preferred stock OID accrual 318,750
Proceeds from stock issuance (ATM facility) 23,469,560
CASH PROVIDED BY FINANCING ACTIVITIES 19,439,281 8,361,290
Net increase (decrease) in cash 2,070,896 (6,357,281)
Cash, beginning of period 5,308,466 16,738,657
Cash, end of period 7,379,362 10,381,376
SUPPLEMENTAL DISCLOSURES    
Cash paid for interest 719,721
Cash paid for income taxes
NON-CASH INVESTING ACTIVITIES    
Lease right to use asset
NON-CASH FINANCING ACTIVITIES    
Common stock, preferred stock and warrants issued (net of forfeitures) in connection with QPhoton, Inc. merger $ (3,785,699) $ 83,083,867
v3.23.3
Nature of the Organization and Business
9 Months Ended
Sep. 30, 2023
Nature of the Organization and Business [Abstract]  
Nature of the Organization and Business

Note 1 – Nature of the Organization and Business

 

Corporate History

 

Quantum Computing Inc. (“QCi” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from “IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to The Nasdaq Stock Market LLC. On June 16, 2022, the Company merged with QPhoton, Inc. (“QPhoton”), a developer of quantum photonic systems and related technologies and applications.

 

Nature of Business

 

The Company is a developer of nanophotonic-based quantum technology, offering real-world, affordable commercial applications. The Company was founded in 2018 by leaders in supercomputing, mathematics, and computer programming to solve the enormous challenge with quantum computing in terms of the high cost and lengthy times required for quantum software development. While much of the market focuses on Quantum Processing Unit (QPU) hardware, the Company’s experts realized that the quantum marketplace and vendors were limiting access to quantum computers due to the complexity of programming them. At the present time, only a very limited number of highly specialized quantum experts are able to use software development toolkits (“SDKs”) to create these critical programs and applications. The Company’s flagship software solution, Qatalyst, has enabled subject matter experts (SMEs) to run existing software on quantum processing units without the need for specialized programming with SDKs. As a result of the merger with QPhoton in June 2022, the Company is now able to offer its software capability that is embedded within its new hardware offering of photonic quantum computing systems and related services.

 

Liquidity

 

On October 28, 2022 the Company filed a shelf registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”), which was declared effective on November 8, 2022 (the “2022 shelf”). Under the 2022 Shelf at the time of effectiveness, the Company had the ability to raise up to $100 million by selling common stock, preferred stock, debt securities, warrants and units. On December 5, 2022, the Company entered into an At-the-Market Issuance Sales Agreement (the “ATM Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”) relating to the sale of its common stock, and incorporated the ATM Agreement into the 2022 Shelf by amendment that was declared effective January 10, 2023. On August 17, 2023, the Company and Ascendiant entered into an amendment (the “ATM Amendment”) to the ATM Agreement, increasing the amount of Common Stock the Company may offer and sell via the “at the market” equity offering program from $25,000,000 to $50,000,000 (the “ATM Upsize”). Following the ATM Upsize, the Company is able to offer and sell shares of Common Stock having an aggregate offering price of up to $27,362,717 via the “at the market” equity offering program. The Company filed a prospectus supplement, dated August 18, 2023 with the Securities and Exchange Commission (the “SEC”) in connection with the offer and sale of the shares pursuant to the ATM Amendment (the “Prospectus Supplement”).

 

Under the terms of the ATM Agreement, as amended, the Company may, but is not obligated to, offer and sell, from time to time, shares of common stock having an aggregate offering price of up to $50 million through Ascendiant. Sales of common stock, if any, will be made by any method permitted that is deemed an “at the market offering” as defined in Rule 415 under the Securities Act. The Company intends to use any net proceeds from the sale of securities for our operations and for other general corporate purposes, including, but not limited to, capital expenditures, general working capital, and possible future acquisitions. There were 15,290,513 shares of common stock sold under the ATM Agreement during the nine months ended September 30, 2023 and no shares of common stock sold under the ATM Agreement during the nine months ended September 30, 2022. As of September 30, 2023, the Company has utilized $23.5 million of the 2022 Shelf. The Company has approximately $76.5 million available under the 2022 Shelf and $26.5 million available under the ATM Agreement, as amended, as of September 30, 2023.

v3.23.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Significant Accounting Policies

Note 2 – Significant Accounting Policies:

 

Basis of Presentation and Principles of Consolidation:

 

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), including ASC 810, Consolidation. The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

The Company’s fiscal year end is December 31.

 

The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern for a period of one year from the issuance of these financial statements. For the period ended September 30, 2023, the Company had $283,154 in revenues, a net loss of $21,424,504 and had net cash used in operations of $14,591,833. Additionally, as of September 30, 2023, the Company had working capital of $20,589 and an accumulated deficit of $141,412,285. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of these unaudited financial statements. The financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.

 

Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company’s patent applications and ultimately achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investments or achieve an adequate sales level.

 

Cash and Cash Equivalents

 

Highly liquid investments with a maturity of three months or less when purchased are considered to be cash equivalents. As of September 30, 2023, the Company had invested $7,171,302 in highly liquid money market funds managed by Morgan Stanley. The Company maintains the balance of its operating cash in deposit accounts with high quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses on these deposits and believes it is not exposed to significant credit risk on cash.

 

Use of Estimates:

 

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the determination of reserves for accounts receivable, stockholders’ equity-based transactions and liquidity assessment. Actual results may differ from these estimates.

 

Revenue

 

The Company recognizes revenue in accordance with ASC 606 – Revenue from Contracts with Customers, by analyzing contracts with its customers using a five-step approach:

 

  1. Identify the contract
     
  2. Identify the performance obligations
     
  3. Determine the transaction price
     
  4. Allocate the transaction price to the performance obligations
     
  5. Recognize revenue when performance obligations are satisfied

 

The Company recognized revenue in 2023 and in 2022 from contracts to perform professional services. Revenue from time and materials-based contracts is recognized as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from units-based contracts is recognized as the number of units delivered or performed during the period times the contractual unit price. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost-plus type contracts at this time.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable principally consists of amounts due from customers for work performed on contracts. The Company records accounts receivable at their net realizable value. Periodically the Company evaluates its accounts receivable to establish an allowance for doubtful accounts, when deemed necessary, based on the history of past write-offs, collections and current credit conditions. During 2022 certain accounts receivable, attributable to a single customer, were determined not to be collectible and management recorded an allowance for doubtful accounts and wrote off the uncollectible receivables against that account. The accounts receivable as of September 30, 2023 and December 31, 2022 are considered fully collectible and thus management has not recorded an allowance for doubtful accounts.

 

Operating Leases - ASC 842

 

The Company has adopted FASB Accounting Standards Codification, or ASC, Topic 842, Leases (“ASC 842”) which requires the recognition of the right-of-use assets and relating operating and finance lease liabilities on the balance sheet. Under ASC 842, all leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases. The lease classification affects the expense recognition in the income statement. Operating lease charges are recorded entirely in operating expenses. Finance lease charges are split, where amortization of the right-of-use asset is recorded in operating expenses and an implied interest component is recorded in interest expense. The expense recognition for operating leases and finance leases under ASC 842 is substantially consistent with ASC 840. As a result, there is no significant difference in our results of operations presented in our consolidated income statement and consolidated statement of comprehensive income for each period presented.

 

We lease substantially all our office space used to conduct our business. At the inception of a contract we assess whether the contract is, or contains, a lease. Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

 

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of these criteria. Substantially all our operating leases are comprised of office space leases and as of December 31, 2022 and September 30, 2023 we had no finance leases.

 

For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. The lease liability represents the present value of the lease payments under the lease. The Company is currently leasing space in four locations, Arlington, VA, Leesburg, VA, Minneapolis, MN and Hoboken, NJ, and we have recognized right-of-use assets and lease liabilities accordingly. The right-of-use asset is initially measured at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. The lease liability is initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, our secured incremental borrowing rate for the same term as the underlying lease. For our real estate and other operating leases, we use our secured incremental borrowing rate. For our finance leases, we use the rate implicit in the lease or our secured incremental borrowing rate if the implicit lease rate cannot be determined.

 

Business Combinations

 

We account for business combinations under the acquisition method of accounting, following ASC 805, Business Combinations. This method requires the recording of acquired assets and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Results of operations related to business combinations are included prospectively beginning with the date of acquisition and transaction costs related to business combinations are recorded withing general and administrative expenses.

 

Property and Equipment

 

Property and equipment are stated at cost or contributed value. Depreciation of furniture, software and equipment is calculated using the straight-line method over their estimated useful lives, and leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the lease term. The cost and related accumulated depreciation of equipment retired or sold are removed from the accounts and any differences between the undepreciated amount and the proceeds from the sale are recorded as a gain or loss on sale of equipment. Maintenance and repairs are charged against expense as incurred.

 

Research and Development Costs

 

Research and development costs include costs directly attributable to the conduct of research and development programs, including the cost of services provided by outside contractors, acquiring work-in-progress intellectual property, development, and mandatory compliance fees and contractual obligations. All costs associated with research and development are expensed as incurred.

 

Stock Based Compensation

 

The Company has adopted Accounting Standards Update (“ASU”) No. 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of ASC 718, Share-Based Payment, to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of ASC 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, and that ASC 718 does not apply to share based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606, Revenue from Contracts with Customers

 

Stock-based compensation expense is recorded for all option grants and awards of non-vested stock and recognized in the financial statements based on the grant date fair value of the awards granted. Stock-based compensation is recognized as expense over the requisite service period, which generally represents the vesting period. The Company calculates the fair value of stock options using the Black-Scholes option-pricing model at grant date. The Company estimates a rate of forfeiture when recording stock option expense. The assumptions and estimates involved in the Black-Scholes model require significant judgement and any changes could have a material impact in the determination of stock-based compensation expense

 

Earnings (Loss) Per Share:

 

Basic earnings (loss) per common share (“EPS”) is based on the number of common shares outstanding during each period presented. Convertible securities, warrants, and options to purchase common stock are included as common stock equivalents only when dilutive. The Company follows the provisions of ASC 260, Diluted Earnings per Share. In computing diluted EPS, basic EPS is adjusted for the assumed issuance of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using the “treasury stock method,” which assumes that the “proceeds” from the exercise of these instruments are used to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred stock is calculated using the “if-converted method,” pursuant to which the securities are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the entire period being presented.

 

The Company had the following common stock equivalents at September 30, 2023 and 2022:

 

   September 30 
   2023   2022 
Common stock   75,094,943    33,904,329 
Series A preferred stock (as converted)   1,564,505    1,575,004 
Series B preferred stock (as converted)   
-
    19,253,920 
Warrants   6,391,024    8,594,796 
Stock options   13,595,929    5,575,528 
Total fully diluted common shares   96,646,401    68,903,577 
v3.23.3
Business Combinations
9 Months Ended
Sep. 30, 2023
Business Combinations [Abstract]  
Business Combinations

Note 3 – Business Combinations

 

Merger with QPhoton, Inc.

 

On May 19, 2022, the Company, QPhoton, and Yuping Huang, the principal stockholder of QPhoton (“Mr. Huang”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which the Company agreed to acquire QPhoton through a series of merger transactions (collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”). On June 16, 2022, all conditions precedent having been met or waived by the parties, the Company closed the Transactions with QPhoton. The merger with QPhoton adds to the Company’s portfolio of quantum computing products and enables the Company to offer a wider range of quantum information services. The Company accounted for the Transactions using the acquisition method in accordance with ASC 805, Business Combinations, with the purchase price being allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their respective estimated fair values on the acquisition date. Fair values were initially determined using management estimates at the time of the merger, then updated in June 2023 for the values attributable to intangible assets based on new information the Company received from a third party valuation. The results of QPhoton are included within the consolidated financial statements commencing on the acquisition date.

 

Pursuant to the Merger Agreement, immediately following the closing of the Transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub I (a wholly owned subsidiary of the Company) merged with and into QPhoton, with QPhoton surviving the merger as a wholly-owned subsidiary of the Company, immediately after which the surviving corporation merged with and into Merger Sub II (also a wholly owned subsidiary of the Company), with Merger Sub II surviving the merger as a wholly-owned subsidiary of the Company (the “Surviving Company”). The merger consideration to be paid to the stockholders of QPhoton (the “Merger Consideration”) consisted of (i) 5,802,206 shares of common stock, par value $0.0001 per share, (ii) 2,377,028 shares of a new series of the Company’s preferred stock, par value $0.0001 per share, to be designated Series B convertible preferred stock (“Series B Preferred Stock”), and (iii) warrants to purchase up to 7,028,337 shares of common stock (the “Warrants”). Each share of Series B Preferred Stock converts into ten (10) shares of common stock. The Merger Consideration for stockholders Yuping Huang and Stevens Institute of Technology was issued in 2022. The other stockholder may have forfeited his rights to the Merger Consideration when he filed a claim asserting Appraisal rights under Delaware law, and pursuant to the terms of the Merger Agreement, all claims to the Merger Consideration had to be submitted to the Company within twelve (12) months of the Closing. However, the Company is in settlement negotiations with the remaining QPhoton stockholder and has decided not to post any adjustment to the purchase price of the Transaction until those negotiations are concluded or abandoned.

 

The purchase price was approximately $83.1 million, consisting of Company Common Stock, Series B Preferred Stock and Warrants. The purchase agreement did not include any contingent consideration. Since the Transactions were structured as an exchange of equity securities, the purchase price was calculated based on the fair market value (in this case the NASDAQ closing price) of the total shares of the Company securities paid to the shareholders of the acquired company, QPhoton. The closing Price of Company Common Stock on June 16, 2022 was $2.27. The total shares of Company Common Stock offered for QPhoton was 36,600,823 – which assumes all of the 2,377,028 Series B Convertible Preferred shares are converted to Common Stock at the 10:1 ratio, and that all 7,028,337 warrants to purchase Common Stock are eventually exercised. The warrants were valued using a Black Scholes formula assuming a maturity of five years, a risk-free interest rate of 2.8%, a volatility of 3.54 and an exercise price of $0.00001. That results in a total value for the Transactions of $83,083,868. This amount will be used as the purchase price. Under ASC 805 transaction costs are required to be expensed so legal and accounting fees incurred for the Transactions were not included in the purchase price.

 

The fair value of the prepaid expenses and security deposits was set at book value, and the fair value of the fixed assets was written up to the purchase cost to reflect the recent purchase dates of the equipment relative to the closing date of the merger. To estimate the fair value of the identifiable intangible assets, the Company recorded an estimate at the time of merger. The Company subsequently engaged a third-party valuation expert (the “Third Party Valuation Expert”), Scalar, LLC, to conduct an independent analysis in line with purchase price accounting standards. The Third Party Valuation Expert concluded:

 

  that there was no fair value attributable to management’s initial estimate of $10,000,000 for customer relationships based on the lack of current customer contracts;

 

  a fair value of $2,722,000 attributable to the non-compete agreement with the founder using the with-and-without method, based on a variation of the income approach, an increase of $2,222,000 in intangibles compared with management’s initial estimate of $500,000. The with-and-without methodology employed uses two scenarios to value the non-compete asset: (1) the “with scenario” captures the estimated cash flows from the business if all of the existing assets were in place including the non-compete asset, and (2) the “without scenario” captures the estimated cash flows from the business if all of the existing assets were in place except the non-compete asset. The difference between the two scenarios is attributed to the presumed loss of cash flows without the non-compete asset in place and represents the value of the non-compete agreement;

 

  a fair value of $969,000 attributable to the QPhoton trade name and trademark using the relief from royalty methodology, a decrease of $31,000 in intangibles compared with management’s initial estimate of $1,000,000. In the application of the relief from royalty method, the Third Party Valuation Expert estimated the value of the trade names/trademarks by capitalizing the royalties saved by virtue of the Company owning the trade names/trademarks. In other words, the Company realizes a benefit from owning the intangible asset rather than paying a rent or royalty for the use of the asset;

 

  a fair value of $12,200,000 attributable to the technology and licensed patents using the relief from royalty methodology, an increase of $477,780 in intangibles compared with management’s initial estimate of $11,722,220. In calculating the fair value of the technology and licensed patents, the Third Party Valuation Expert followed the same approach as the trade name/trademark analysis; and

 

  that there was no identifiable intangible value attributable to management’s initial estimate of $2,250,000 for employee agreements, rather calculated a fair value of $1,912,000 included in goodwill attributable to the assembled workforce using the replacement cost method.  The replacement cost method approximates the cost it would take to reconstruct an asset of similar utility (to create a substitute asset). Specifically, this approach considers all of the costs the Company would have incurred to replace the QPhoton workforce with a brand new (but comparable) workforce. The assembled workforce value is added to goodwill per ASC 805-20-55-6, Assembled Workforce and Other Items that Are not Identifiable, and not tracked separately as an amortizing intangible asset.

 

The Company accepted the Third Party Valuation Expert’s valuation without adjustment.

 

The following table summarizes the adjusted acquisition date fair values of assets acquired and liabilities assumed by the Company, including the final results of the analysis performed by the Third Party Valuation Expert for the intangibles:

 

Purchase price, net of cash acquired  $81,939,939 
Less     
Prepaid expenses   16,109 
Fixed assets at cost   116,315 
Security deposits   97,768 
Non-compete agreement with founder   2,722,000 
Website domain, trade name and trademark   969,000 
Technology and licensed patents   12,200,000 
Accounts payable and other current liabilities   (2,888,246)
Goodwill  $68,706,993 

 

The purchase price and purchase price allocation for QPhoton was initially considered finalized as of September 30, 2022, then was subsequently revised after the Company received new information from the Third Party Valuation Expert’s valuation of intangibles. The following table summarizes the changes of intangibles, which resulted in an increase to goodwill of $9,581,220 compared to initial purchase price allocation estimates reported in the Company’s Form 10-Q: Quarterly report for quarter ending June 30, 2022.

 

   Initial
Valuation
   Final   Increase 
Intangible Assets  Estimate   Valuation   (Decrease) 
Customer relationships  $10,000,000   $
-
   $(10,000,000)
Non-compete agreement with founder   500,000    2,722,000    2,222,000 
Website domain, trade name and trademark   1,000,000    969,000    (31,000)
Employment agreements   2,250,000    
-
    (2,250,000)
Technology and licensed patents   11,722,220    12,200,000    477,780 
Total  $25,472,220   $15,891,000    (9,581,220)

 

Based on the adjusted purchase price allocation, the goodwill recognized was $68.7 million, which is not expected to be deductible for income tax purposes. The amount allocated to goodwill and intangible assets reflected the benefits the Company expected to realize from the growth of the acquisition’s operations. 

 

Note Purchase Agreement – the Company and QPhoton

 

On February 18, 2022, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with QPhoton, pursuant to which the Company agreed to loan money to QPhoton using two unsecured promissory notes (each, a “Note”), each in the principal amount of $1,250,000, subject to the terms and conditions of the Note Purchase Agreement. Also on February 18, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1,250,000 to QPhoton. On April 1, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1,250,000 to QPhoton, for a total loan under the two Notes of $2,500,000.

 

The Note Purchase Agreement contains customary representations and warranties by QPhoton and the Company, as well as a “most favored nations” provision for the benefit of the Company. The Notes issued under the Note Purchase Agreement, including the Notes issued on February 18, 2022 and April 1, 2022, provide that the indebtedness evidenced by the applicable Note bears simple interest at the rate of 6% per annum (or 15% per annum during the occurrence of an event of default, as defined in the Notes), and becomes due and payable in full on the earlier of (i) March 1, 2023, subject to extension by one year at the option of QPhoton, (ii) a change of control (as defined in the Notes) of QPhoton or (iii) an event of default. As a result of the merger, the Notes and accrued interest are eliminated through consolidation. However, the two Notes have not been forgiven or converted to equity.

v3.23.3
Intangible Assets and Goodwill
9 Months Ended
Sep. 30, 2023
Intangible Assets and Goodwill [Abstract]  
Intangible Assets and Goodwill

Note 4 – Intangible Assets and Goodwill

 

As a result of the merger with QPhoton, the Company has the following amounts related to intangible assets:

 

   Intangible Assets as of:     
   September 30,   December 31,   Amortizable 
Amortizable Intangible Assets  2023   2022   Life 
Customer relationships   
-
    10,000,000    3 years 
Non-compete agreement with founder   2,722,000    500,000    3 years 
Website domain, trade name and trademark   969,000    1,000,000    5 years 
Employment agreements   
-
    2,250,000    2 years 
Technology and licensed patents   12,200,000    11,722,220    10 years 
Less: accumulated amortization   (3,791,987)   (3,248,495)     
Net intangible assets  $12,099,013   $22,223,725      

 

The aggregate amortization expense of the Company’s intangible assets for the periods ended September 30, 2023 and December 31, 2022 was $543,492 and $3,248,495, respectively, driven by the purchase price allocation adjustments to initial estimates realized in the period ended June 30, 2023. The Company expects future amortization expense to be the following:

 

   Amortization 
Balance of 2023  $2,132,993 
2024   2,843,991 
2025   2,352,518 
2026   1,936,657 
2027   1,831,682 
Thereafter (2028-2032)   2,423,167 
Total  $12,099,013 

 

The Company recorded goodwill resulting from the merger with QPhoton, calculated as the difference between the total purchase price and the value of tangible and intangible assets acquired less the liabilities assumed. The Company recorded goodwill of $65,106,678 resulting from the QPhoton merger. The following table provides a summary of the changes in goodwill for the periods ended September 30, 2023 and December 31, 2022:

 

   September 30,   December 31, 
   2022   2022 
Goodwill, at beginning of year  $59,125,773   $
-
 
Goodwill additions or adjustments   9,581,220    59,125,773 
Goodwill reduction or impairment   3,785,699    
-
 
Goodwill, at end of year  $64,921,294   $59,125,773 

 

The Company tested the intangible assets and goodwill for impairment as of December 31, 2022 and concluded there was no impairment of intangible assets or goodwill at that time. For the period ended September 30, 2023, the Company realized $3,785,699 in reductions to goodwill related to forfeitures of warrants issued and reserved in connection with the QPhoton merger on June 16, 2022 (“QPhoton Merger Consideration Warrants”). The QPhoton Merger Consideration Warrants are forfeited on a pro rata basis when and if stock options and warrants issued and outstanding as of June 15, 2022 are forfeited. Additionally, the Company increased goodwill, as a reclassification from intangible assets, by $9,581,220 to record the adjustments resulting from the Third Pary Valuation Expert’s valuation as compared to initial estimates in the QPhoton purchase price allocation in the period ended June 30, 2023.

v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Taxes [Abstract]  
Income Taxes

Note 5 – Income Taxes:

 

The Company has made no provision for income taxes because there has been no taxable income.

 

FASB has issued Statement of Financial Accounting Standards Number 109 (“SFAS 109”), “Accounting for Income Taxes”, which requires a change from the deferred method to the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities.

 

   September 30, 
   2023   2022 
Net operating loss carry-forwards  $13,136,072   $8,369,585 
Valuation allowance   (13,136,072)   (8,369,585)
Net deferred tax assets  $
-
   $
-
 

 

At September 30, 2023, the Company had net operating loss carry forwards of approximately $13,136,072.

 

Net operating loss carryforwards are subject to limitations under Section 382 of the Internal Revenue Code and the Company anticipates that no more than an insignificant portion of this net operating allowance will ever be used against future taxable income. FASB Codification ASC 740 requires changes in recognition and measurement for uncertain tax positions. The Company has analyzed its tax positions and concluded that it is not aware of any uncertain tax positions. If this conclusion changes, the Company will assess the impact of any such changes on its financial position and the results of operations.

v3.23.3
Financial Accounting Developments
9 Months Ended
Sep. 30, 2023
Financial Accounting Developments [Abstract]  
Financial Accounting Developments

Note 6 – Financial Accounting Developments:

 

Recently Issued Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. The Company has evaluated the recently implemented accounting standards and concluded that none currently apply to the Company.

v3.23.3
Property and Equipment
9 Months Ended
Sep. 30, 2023
Property and Equipment [Abstract]  
Property and Equipment

Note 7 – Property and Equipment

 

   September 30,   December 31, 
Classification  2023   2022 
Hardware & Equipment  $3,171,835   $1,026,829 
Software   38,484    18,889 
Total cost of property and equipment   3,210,319    1,045,718 
Accumulated depreciation   252,032    70,549 
Property and equipment, net  $2,958,287   $975,169 

 

The Company acquired $2,164,601 of property and equipment during the nine months ended September 30, 2023. It is the Company’s policy to capitalize purchases of property and equipment with a cost of $2,500 or more that benefit future periods.

 

   Estimated
Useful Life
(Years)
 
Computer and laboratory equipment  5 
Network equipment  4 
Minor equipment  3 
Furniture and fixtures  7 
Software  3 
Leasehold improvements  5 

 

Maintenance and repairs are charged to operations when incurred. When property and equipment are sold or otherwise disposed, the asset account and related accumulated depreciation and amortization accounts are relieved, and any gain or loss is included in other income or expense.

v3.23.3
Loans
9 Months Ended
Sep. 30, 2023
Loans [Abstract]  
Loans

Note 8 – Loans

 

Notes Payable – BV Advisory Partners, LLC

 

As part of our business combination with QPhoton in June 2022, we acquired a note payable to BV Advisory Partners, LLC. On March 1, 2021, QPhoton entered into a Note Purchase Agreement with BV Advisory. Under the Note Purchase Agreement, on March 1, 2021, March 23, 2021 and July 9, 2021, BV Advisory, a related party shareholder, purchased convertible promissory notes from QPhoton for $200,592, $150,000, and $150,000, respectively, for a total of $500,592 (the “BV Notes”). The BV Notes all bore interest at a rate of 6% per annum and matured 2 years from the grant date. However, QPhoton only received approximately $375,000 in cash proceeds as $125,041 was paid by BV Advisory directly to The Trustees of the Stevens Institute of Technology (“Stevens Institute”) on behalf of QPhoton, to satisfy QPhoton’s obligations to reimburse costs incurred under the terms of their patent license agreement with the Stevens Institute.

 

On June 16, 2022 the Company tendered a cashier’s check to BV Advisory in the amount of $535,68.44, representing the full principal balance of the BV Notes and accrued interest through June 16, 2022. On July 14, 2022 BV Advisory returned the cashier’s check and disputed the calculation of the amount paid to settle the BV Notes. The BV Notes and accrued interest are recorded as short-term liabilities. On August 15, 2022, BV Advisory Partners, LLC (“BV Advisory”) filed a complaint in the Court of Chancery of the State of Delaware naming the Company and certain of its directors and officers (among others) as defendants (the “Lawsuit”). BV Advisory Partners, LLC v. Quantum Computing Inc., et al., C.A. No. 2022-0719-VCG (Del. Ch.). BV Advisory is seeking, among other relief, monetary damages for an alleged breach of the Note Purchase Agreement between BV Advisory and QPhoton, Inc., the predecessor in interest to QPhoton, LLC, a wholly-owned subsidiary of the Company, as well as monetary damages for breach of an alleged binding letter of intent among Barksdale Global Holdings, LLC, Inference Ventures, LLC and QPhoton, Inc. The Company believes that BV Advisory’s claims have no merit and intends to defend itself vigorously. The Company filed a motion to dismiss the complaint in December 2022, and in March 2023 Plaintiff filed a second amended complaint. The Company filed a motion to dismiss the second amended complaint, oral argument was held on October 11, 2023 and at this time that motion is pending before the Court. The Company does not believe it is necessary to accrue an amount in addition to the principal and interest on the BV Notes at this time.

 

Unsecured Promissory Note

 

On September 23, 2022, the Company entered into a note purchase agreement (the “NPA”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which Streeterville purchased an unsecured promissory note (the “Note” or the “Streeterville Unsecured Note”) in the initial principal amount of $8,250,000. The Note bears interest at 10% per annum. The maturity date of the Note is 18 months from the date of its issuance (the “Maturity Date”). The Note carries an original issue discount of $750,000, which is included in the principal balance of the Note. If the Company elects to prepay the Note prior to the Maturity Date, it must pay to Investor 120% of the portion of the Outstanding Balance the Company elects to prepay.

 

Beginning on the date that is six (6) months after the issuance date of the Note, Streeterville has the right to redeem up to $750,000 of the outstanding balance of the Note per month (“Redemption Amount”) by providing written notice to the Company (“Redemption Notice”). Upon receipt of any Redemption Notice, the Company shall pay the applicable Redemption Amount in cash to Streeterville within three (3) trading days of the Company’s receipt of such Redemption Notice. No prepayment premium shall be payable in respect of any Redemption Amount. As of September 30, 2023, Streeterville has redeemed $4,750,000 of the outstanding balance of the Note.

 

Pursuant to the terms of the NPA, the parties provided customary representations and warranties to each other. Also, until amounts due under the Note are paid in full, the Company agreed, among other things, to: (i) timely make all filings under the Securities Exchange Act of 1934, (ii) ensure the common stock continues to be listed on the Nasdaq Stock Market LLC (iii) ensure trading in the common stock will not be suspended, halted, chilled, frozen, reach zero bid or otherwise cease trading on the Company’s principal trading market, (iv) ensure the Company will not make any Restricted Issuance (as defined in the Note) without Investor’s prior written consent, which consent may be granted or withheld in Investor’s sole and absolute discretion, (v) ensure the Company shall not enter into any agreement or otherwise agree to any covenant, condition, or obligation that locks up, restricts in any way or otherwise prohibits the Company from entering into certain additional transactions with Streeterville, and (vi) with the exception for Permitted Liens (as defined in the Note), ensure the Company will not pledge or grant a security interest in any of its assets without Streeterville’s prior written consent, which consent may be granted or withheld in Streeterville’s sole and absolute discretion.

 

The Note sets forth certain standard events of default (such event, an “Event of Default”) that generally, if uncured within seven (7) trading days, may result in the discretion of Streeterville in certain penalties under the terms of the Note. In this regard, upon an Event of Default, Streeterville may accelerate the Note by written notice to the Company, with the outstanding balance becoming immediately due and payable in cash at the Mandatory Default Amount (as defined in the Note). Additionally, upon written notice given by Streeterville to the Company, interest shall accrue on the Outstanding Balance beginning on the date the applicable Event of Default occurred at an interest rate equal to the lesser of fifteen percent (15%) per annum simple interest or the maximum rate permitted under applicable law upon an Event of Default.

 

Note Purchase Agreement Loan

 

On May 16, 2023, the Company entered into a Summary of Proposed Terms (the “Letter of Intent”) with millionways, Inc. (“millionways”) to provide bridge loans to millionways and enter into due diligence to acquire up to 100% of the AI firm. On June 6, 2023, the Company entered into a Note Purchase Agreement (the “MW Agreement”) with millionways, pursuant to which the Company agreed to purchase from millionways up to three unsecured promissory notes (each, a “MW Note”), in an aggregate principal amount of up to $2,000,000, subject to the terms and conditions of the MW Agreement. Also on June 6, 2023, pursuant to the terms of the MW Agreement, the Company purchased the MW Notes from millionways and loaned an aggregate principal amount of $500,000 to millionways.

 

The MW Agreement contains customary representations and warranties by millionways and the Company, as well as a “most favored nations” provision for the benefit of the Company. The MW Notes issued under the MW Agreement, including the MW Notes issued on June 6, 2023, provide that the indebtedness evidenced by the applicable MW Note bears simple interest at the rate of 10% per annum (or 15% per annum during the occurrence of an event of default, as defined in the MW Notes), and becomes due and payable in full on the earlier of (i) May 16, 2024, (ii) a change of control (as defined in the MW Notes) of millionways, (iii) dollar-for-dollar prepayment for additional capital received through any vehicle from a third party or (iv) an event of default. 

v3.23.3
Capital Stock
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Capital Stock

Note 9 – Capital Stock:

 

Series A Convertible Preferred Offering

 

From November 10, 2021 through November 17, 2021, the Company conducted a private placement offering (the “Private Placement”) pursuant to securities purchase agreements with 7 accredited investors (the “Series A Investors”), whereby the Series A Investors purchased from the Company an aggregate of 1,545,459 shares of the Company’s newly created Series A Convertible Preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”) and warrants to purchase 1,545,459 shares of common stock for an aggregate purchase price of $8,500,000. The Private Placement was completed and closed to further investment on November 17, 2021.

 

The Series A Preferred Stock ranks senior to common stock with respect to the payment of dividends and liquidation rights. Each holder of Series A Preferred Stock is entitled to receive, with respect to each share of Series A Preferred Stock then outstanding and held by such holder, dividends at the rate of ten percent (10%) per annum (the “Preferred Dividends.”) The Company is obligated to pay the Preferred Dividends quarterly, in arrears, within fifteen (15) days of the end of each quarter. The Company has the option to pay the Preferred Dividends in cash or in common stock, at a price per share of common stock equal to the average of the closing sale price of the common stock for the five (5) trading days preceding the applicable dividend payment date. The Preferred Dividends are accrued monthly, but not compounded, and are recorded as interest expense, because the Preferred Dividends are mandatory and not declared at the discretion of the Board of Directors.

 

The number of shares of common stock issuable upon conversion of any share of Series A Preferred Stock shall be determined by dividing (x) the Conversion Amount of such share of Series A Preferred Stock by (y) the Conversion Price. “Conversion Amount” means, with respect to each share of Series A Preferred Stock, as of the applicable date of determination, the sum of (1) the stated value thereof plus (2) any accrued dividends. “Conversion Price” means, with respect to each share of Series A Preferred Stock, as of any optional conversion date, Mandatory Conversion Date or other date of determination, $5.50, subject to adjustment for stock splits, dividends, recapitalizations and similar corporate events.

 

The Warrants are two-year warrants to purchase shares of common stock at an exercise price of $7.00 per share, subject to adjustment, and are exercisable at any time on or after the date that is six (6) months following the issuance date. The warrants provide for cashless exercise in the event the underlying shares of common stock are not registered.

 

In connection with the Purchase Agreement, the Company and the Series A Investors entered into a registration rights agreement (the “Registration Rights Agreement”) pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days. Pursuant to the Registration Rights Agreement, the Series A Investors received certain rights, including but not limited to piggyback registration rights, providing that the holder be given notice of any proposed registration of securities by the Company, and requiring that the Company register all or any portion of the registrable securities that the holders request to be registered, in each case, subject to the terms and conditions of the Registration Rights Agreement.

 

On April 27, 2022 the Company filed a Resale Form S-3 as required by the Registration Rights Agreement, pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days from the closing of the Private Placement. The Resale Form S-3 went effective on June 2, 2022.

 

On June 13, 2022, one of the Series A Investors, Falcon Capital Partners, converted 45,455 shares of Series A Convertible Preferred stock into 47,728 shares of common stock.

 

On February 9, 2023, one of the Series A Investors, Greenfield Children, LLC, converted 10,000 shares of Series A Convertible Preferred stock plus accrued dividends into 11,096 shares of common stock.

 

Other Offerings

 

On October 11, 2022 the Company issued 155,000 shares of common stock to seven employees and consultants in exchange for services rendered.

 

On January 20, 2023 the Company issued 750,000 shares of common stock to Draper, Inc. and 750,000 shares of common stock to Carriage House Capital, Inc. as compensation for services rendered in support of the QPhoton merger.

 

On May 3, 2023 the Company issued 853,600 shares of common stock to thirty-five (35) employees as payment in lieu of cash for 2022 performance bonuses (the “Bonus Shares”). The Bonus Shares are restricted and will vest as follows: one half vesting on December 31, 2023 and one half vesting on December 31, 2024. As of September 30, 2023 the Company canceled 23,600 of the issued shares that were forfeited by employees no longer with the Company.

 

From January 19 through September 30, 2023, the Company sold 15,290,513 shares of common stock through its At-The-Market (ATM) facility, managed by Ascendiant Capital, at an average price of $1.53. The Company received gross proceeds of $23,469,560 and paid a fee of three percent (3%) to Ascendiant Capital.

v3.23.3
Stock Based Compensation
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation

Note 10 – Stock Based Compensation

 

Incentive Plans and Options

 

The Company’s 2019 Equity and Incentive Plan, as amended in 2021 (the “2019 Plan”) enabled the Company to grant incentive stock options or nonqualified stock options and other equity awards to employees, directors and consultants of the Company up to a total of 3,000,000 shares of common stock. All 3,000,000 shares available for issue under the 2019 Plan have been issued.

 

On July 5, 2022, the Board of Directors adopted the Company’s 2022 Equity and Incentive Plan (the “2022 Plan”) which provides for the issuance of up to 16,000,000 shares of common stock. The 2022 Plan was approved by a majority of the shareholders in September 2022. Per the 2022 Plan, the 2022 Plan reserves increased automatically by 1,000,000 shares on January 1, 2023, providing for a total issuance of up to 17,000,000 shares of common stock. As of September 30, 2023, a total of 13,595,929 shares and options were issued and outstanding under the 2022 Plan.

 

The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:

 

   Nine and Twelve
Months Ended
  
   September 30,  December 31,  
   2023  2022  
Exercise price  $ 1.35 – 1.84  $ 5.20 – 12.72  
Risk-free interest rate   4.68 – 4.81%  0.04 – 0.08% 
Expected volatility   200 – 214%  390 – 415% 
Expected dividend yield   0%  0% 
Expected life of options (in years)   5.0   5.0  

 

The following table summarizes the Company’s option activity since December 31, 2022:

 

       Weighted     
       Average   Contractual 
   Number of   Exercise   Term 
   Shares   Price   (in years) 
Outstanding as of December 31, 2022   9,601,237   $3.42    4.0 
Granted   4,342,500    1.42    5.0 
Exercised   
-
    
-
    
-
 
Forfeited   347,808    5.77    
-
 
Outstanding as of September 30, 2023   13,595,929   $2.72    3.6 
Vested as of September 30, 2023   7,857,651   $3.37    3.3 

 

The following table summarizes the exercise price range as of September 30, 2023:

 

Exercise Price   Outstanding Options   Exercisable Options 
$1.00    408,970    408,970 
$1.35    3,750,000    
-
 
$1.45    225,000    225,000 
$1.67    50,000    16,665 
$1.84    592,500    300,000 
$1.95    280,000    280,000 
$2.37    5,090,459    4,388,447 
$2.40    1,055,000    525,006 
$2.56    287,500    95,822 
$2.61    150,000    97,226 
$3.58    65,000    43,335 
$3.98    66,000    66,000 
$5.69    12,500    12,500 
$5.70    25,000    16,667 
$6.49    50,000    33,333 
$6.85    650,000    566,675 
$7.00    18,000    12,000 
$7.55    7,500    7,500 
$8.85    100,000    66,670 
$10.00    650,000    650,000 
$11.51    50,000    33,335 
$11.65    12,500    12,500 
      13,595,929    7,857,651 

 

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2023 and twelve months ended December 31, 2022 was $1.42 per share and $2.38 per share, respectively. 

 

Stock-based compensation

 

The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss:

 

   Nine and Twelve
Months Ended
 
   September 30,
2023
   December 31,
2022
 
Research and development   2,273,846    2,758,465 
General and administrative   3,619,450    15,003,002 
Total stock-based compensation  $5,893,296   $17,761,467 

 

As of September 30, 2023, total unrecognized compensation cost related to common stock options was $7.0 million, which is expected to be recognized over a period of 4.3 years.

 

Warrants

 

In connection with a restricted stock units offering in June 2020, the Company issued warrants in August 2020 to purchase 171,000 shares of common stock at an exercise price of $2.00/share. Those warrants are exercisable for five years from the date of issuance. In connection with an offering of Series A Convertible Preferred stock in November 2021, the Company issued warrants to purchase 1,545,459 shares of common stock at an exercise price of $7.00. Those warrants are exercisable for two years from the date of issuance. In connection with the QPhoton merger on June 16, 2022, the Company issued warrants to purchase 6,325,503 shares of common stock at an exercise price of $0.0001. Those warrants are exercisable when and if stock options and warrants issued and outstanding as of June 15, 2022 are exercised. The following table summarizes the warrants outstanding at September 30, 2023:

 

Issuance Date  Expiration Date  Exercise Price   Issued   Exercised   Forfeited /
Canceled
   Warrants
Outstanding
 
August 18, 2020  August 18, 2025  $2.00    171,000    (150,000)   
-
    21,000 
November 15, 2021  November 15, 2023  $7.00    1,545,459    
-
    
-
    1,545,459 
June 16, 2022  May 9, 2027  $0.0001    6,325,503    
-
    (1,500,938)   4,824,565 
v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

There were no related party transactions during the nine-month periods ended September 30, 2023 and 2022. 

v3.23.3
Operating Leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Operating Leases

Note 12 – Operating Leases:

 

The Company leases space in four different locations, Arlington, VA, Leesburg, VA, Hoboken, NJ and Minneapolis, MN, under lease agreements which expire at various dates through September 30, 2027. The Company’s leases do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease assets and liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease.

 

The table below reconciles the undiscounted future minimum lease payments under these operating leases to the total operating lease liabilities recognized on the consolidated balance sheet as of September 30, 2023:

 

Year  Lease
Payments
Due
 
Balance of 2023  $47,135 
2024  $344,732 
2025  $341,081 
2026  $349,608 
2027  $267,092 
Less: imputed Interest  $(301,334)
Present Value of operating lease liabilities  $1,048,313 

 

Other information related to operating lease liabilities consists of the following:

 

   Six and Twelve
Months Ended
 
   September 30,
2023
   December 31,
2022
 
         
Cash paid for operating lease liabilities  $314,498   $125,238 
Weighted average remaining lease term in years   3.9    4.7 
Weighted average discount rate   10%   10%
v3.23.3
License Agreement – Stevens Institute of Technology
9 Months Ended
Sep. 30, 2023
License Agreement – Stevens Institute of Technology [Abstract]  
License Agreement – Stevens Institute of Technology

Note 13 – License Agreement – Stevens Institute of Technology

 

Effective December 17, 2020, QPhoton signed a License Agreement with the Stevens Institute. The License Agreement enables the Company to commercially use technology such as licensed patents, licensed patent applications and licensed “Know-How”. QPhoton is also able to issue sublicenses for the technology under the agreement. The agreement is effective until the later of: (i) the 30-year anniversary of the effective date, or (ii) the expiration of the licensed patent or licensed patent application that is last to expire. As part of the merger of the Company and QPhoton, the Stevens License Agreement was assigned to the Company.

 

During the term of the agreement and prior to any commercialization or sublicensing of the technology by the Company, the Company shall be required to submit annual reports to the Stevens Institute reporting on all research, development, and efforts toward commercialization and/or sublicensing made during the year. Once any commercialization and/or sublicensing has been initiated, the Company shall deliver quarterly reports to the Stevens Institute reporting on the revenue received by the Company, all sublicenses derived from the sale of licensed products, and the net sales price associated with each transaction. The Company will be responsible for reimbursing Stevens for any costs associated with the prosecution and maintenance of the licensed patents and licensed patent applications moving forward.

 

Consideration for the agreement

 

As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35,000 within 30 days of execution of the agreement, (ii) $28,000 within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the outstanding equity of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the net sales price of each licensed product sold or licensed by the company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.

 

As of September 30, 2023 the Company has begun to commercialize some of the licensed technology, though has not recorded any related revenue and hence has not incurred any royalty expenses payable to the Stevens Institute.

v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 14 – Subsequent Events:

 

On October 3, 2023, the Company’s Federal subsidiary, QI Solutions, demonstrated unprecedented capability to detect landmines up to 2.5 feet below dense underground surface. The successful validation of Quantum Photonic Detection and Ranging (QpDAR) VX3, conducted from September 11-14, 2023, in a field environment, mimicking real-world conditions – demonstrated, the ability of the VX3 sensor to harness Quantum Single Photon Detection (QSPD) to detect landmines and unexploded ordnances (UXOs) from surface level to depths up to 30-inches. Landmines are a pervasive legacy of war that kill thousands of innocent civilians every year. According to United Nations News, currently there are approximately 70 countries and territories contaminated by roughly 110 million landmines. Landmines kill and maim up to 1,000 to 2,000 people every month, most of whom are civilians and children. In many of the most affected areas of the world, where agriculture is the mainstay of the economy, landmines were planted in fields, forests, around wells, water sources and hydroelectric installations, making the farmland unusable or usable only at great risk NATO, Department of State humanitarian programs, and multiple countries in Europe and Southeast Asia have commenced engagements to bring this technology to the field immediately.

 

On October 31, 2023, the Company signed contracts for its first sales of its Reservoir Computer and its Quantum Random Number Generator products to its partners’ Assured Cyber Protection Ltd and AI firm millionways to enhance their AI capabilities. These sales kick off the Company’s commercial delivery of its computing technologies. The QCi Reservoir Computer is a first-to-market portable device with technology inspired by the power of quantum mechanics. The device can perform complex computational tasks with unprecedented speed and efficiency to facilitate data analysis, machine learning and artificial intelligence. Its minimal size, weight, power, and cost factors make it particularly suitable for use as an edge computing tool. QCi’s Reservoir Computer uses the Company’s proprietary capabilities to create a small footprint hardware device that requires 80% to 95% less power consumption than conventional silicon-based computers. Additionally, the QCi Quantum Random Number Generator (QRNG) enables true randomness for applications in cryptography, secure communications, and data encryption. By integrating QCi’s Reservoir Computer and QRNG into their security algorithms, Assured Cyber Protection Ltd aims to enhance its ability to detect and respond to cyberattacks in real-time, staying ahead of cybercriminals in this ever-shifting landscape. The addition of QCi’s Reservoir Computer to millionways’ assessment process is expected to significantly boost machine learning efficiency, particularly in assessing audio files, dramatically reduce the power consumption and materially speed up the “training” of machine learning models.

 

On July 27, 2023, BV Advisory Partners, LLC, and its chief executive officer, Keith Barksdale, alleged stockholders of and claimants against the Company, filed a petition in the Court of Chancery of the State of Delaware to appoint a receiver for the Company (the “Petition”) based on allegations that the Company is insolvent. The Petition also objects to the Company’s approach to raising capital. In a related motion, the petitioners also sought expedited treatment of the petition on July 28, 2023 under the presumption that they allegedly face a threat of irreparable harm. The Company has strong defenses against the allegations in the Petition, considers the claims baseless and without merit, has moved to dismiss the Petition, and intends to vigorously defend itself against these baseless allegations. Among many other issues, the Company opposes the Petition in light of the fact that two of Mr. Barksdale’s own companies either filed for bankruptcy or were sold under Sheriff Auction within the last 12 months. Following oral arguments before the Delaware Chancery Court on October 11, 2023, the presiding judge denied BV Advisory Partners’ motion to expedite and took the Company’s motion to dismiss the Petition under advisement.

 

From October 1, 2023 through November 10, 2023, the Company repaid $1,500,000 of principal and accrued interest on the Streeterville Note, for a cumulative redemption amount of $6,250,000. As of November 10, 2023, the remaining principal and accrued interest payable is $2,786,528.

 

There are no other events of a subsequent nature that in management’s opinion are reportable.

v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation:

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), including ASC 810, Consolidation. The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

The Company’s fiscal year end is December 31.

The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern for a period of one year from the issuance of these financial statements. For the period ended September 30, 2023, the Company had $283,154 in revenues, a net loss of $21,424,504 and had net cash used in operations of $14,591,833. Additionally, as of September 30, 2023, the Company had working capital of $20,589 and an accumulated deficit of $141,412,285. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of these unaudited financial statements. The financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.

Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company’s patent applications and ultimately achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investments or achieve an adequate sales level.

Cash and Cash Equivalents

Cash and Cash Equivalents

Highly liquid investments with a maturity of three months or less when purchased are considered to be cash equivalents. As of September 30, 2023, the Company had invested $7,171,302 in highly liquid money market funds managed by Morgan Stanley. The Company maintains the balance of its operating cash in deposit accounts with high quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses on these deposits and believes it is not exposed to significant credit risk on cash.

Use of Estimates

Use of Estimates:

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the determination of reserves for accounts receivable, stockholders’ equity-based transactions and liquidity assessment. Actual results may differ from these estimates.

 

Revenue

Revenue

The Company recognizes revenue in accordance with ASC 606 – Revenue from Contracts with Customers, by analyzing contracts with its customers using a five-step approach:

  1. Identify the contract
     
  2. Identify the performance obligations
     
  3. Determine the transaction price
     
  4. Allocate the transaction price to the performance obligations
     
  5. Recognize revenue when performance obligations are satisfied

The Company recognized revenue in 2023 and in 2022 from contracts to perform professional services. Revenue from time and materials-based contracts is recognized as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from units-based contracts is recognized as the number of units delivered or performed during the period times the contractual unit price. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost-plus type contracts at this time.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable principally consists of amounts due from customers for work performed on contracts. The Company records accounts receivable at their net realizable value. Periodically the Company evaluates its accounts receivable to establish an allowance for doubtful accounts, when deemed necessary, based on the history of past write-offs, collections and current credit conditions. During 2022 certain accounts receivable, attributable to a single customer, were determined not to be collectible and management recorded an allowance for doubtful accounts and wrote off the uncollectible receivables against that account. The accounts receivable as of September 30, 2023 and December 31, 2022 are considered fully collectible and thus management has not recorded an allowance for doubtful accounts.

 

Operating Leases - ASC 842

Operating Leases - ASC 842

The Company has adopted FASB Accounting Standards Codification, or ASC, Topic 842, Leases (“ASC 842”) which requires the recognition of the right-of-use assets and relating operating and finance lease liabilities on the balance sheet. Under ASC 842, all leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases. The lease classification affects the expense recognition in the income statement. Operating lease charges are recorded entirely in operating expenses. Finance lease charges are split, where amortization of the right-of-use asset is recorded in operating expenses and an implied interest component is recorded in interest expense. The expense recognition for operating leases and finance leases under ASC 842 is substantially consistent with ASC 840. As a result, there is no significant difference in our results of operations presented in our consolidated income statement and consolidated statement of comprehensive income for each period presented.

We lease substantially all our office space used to conduct our business. At the inception of a contract we assess whether the contract is, or contains, a lease. Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. At inception of a lease, we allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of these criteria. Substantially all our operating leases are comprised of office space leases and as of December 31, 2022 and September 30, 2023 we had no finance leases.

For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. The lease liability represents the present value of the lease payments under the lease. The Company is currently leasing space in four locations, Arlington, VA, Leesburg, VA, Minneapolis, MN and Hoboken, NJ, and we have recognized right-of-use assets and lease liabilities accordingly. The right-of-use asset is initially measured at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. The lease liability is initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, our secured incremental borrowing rate for the same term as the underlying lease. For our real estate and other operating leases, we use our secured incremental borrowing rate. For our finance leases, we use the rate implicit in the lease or our secured incremental borrowing rate if the implicit lease rate cannot be determined.

Business Combinations

Business Combinations

We account for business combinations under the acquisition method of accounting, following ASC 805, Business Combinations. This method requires the recording of acquired assets and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Results of operations related to business combinations are included prospectively beginning with the date of acquisition and transaction costs related to business combinations are recorded withing general and administrative expenses.

 

Property and Equipment

Property and Equipment

Property and equipment are stated at cost or contributed value. Depreciation of furniture, software and equipment is calculated using the straight-line method over their estimated useful lives, and leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the lease term. The cost and related accumulated depreciation of equipment retired or sold are removed from the accounts and any differences between the undepreciated amount and the proceeds from the sale are recorded as a gain or loss on sale of equipment. Maintenance and repairs are charged against expense as incurred.

Research and Development Costs

Research and Development Costs

Research and development costs include costs directly attributable to the conduct of research and development programs, including the cost of services provided by outside contractors, acquiring work-in-progress intellectual property, development, and mandatory compliance fees and contractual obligations. All costs associated with research and development are expensed as incurred.

Stock Based Compensation

Stock Based Compensation

The Company has adopted Accounting Standards Update (“ASU”) No. 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of ASC 718, Share-Based Payment, to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of ASC 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, and that ASC 718 does not apply to share based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606, Revenue from Contracts with Customers

Stock-based compensation expense is recorded for all option grants and awards of non-vested stock and recognized in the financial statements based on the grant date fair value of the awards granted. Stock-based compensation is recognized as expense over the requisite service period, which generally represents the vesting period. The Company calculates the fair value of stock options using the Black-Scholes option-pricing model at grant date. The Company estimates a rate of forfeiture when recording stock option expense. The assumptions and estimates involved in the Black-Scholes model require significant judgement and any changes could have a material impact in the determination of stock-based compensation expense

 

Earnings (Loss) Per Share

Earnings (Loss) Per Share:

Basic earnings (loss) per common share (“EPS”) is based on the number of common shares outstanding during each period presented. Convertible securities, warrants, and options to purchase common stock are included as common stock equivalents only when dilutive. The Company follows the provisions of ASC 260, Diluted Earnings per Share. In computing diluted EPS, basic EPS is adjusted for the assumed issuance of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using the “treasury stock method,” which assumes that the “proceeds” from the exercise of these instruments are used to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred stock is calculated using the “if-converted method,” pursuant to which the securities are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the entire period being presented.

The Company had the following common stock equivalents at September 30, 2023 and 2022:

   September 30 
   2023   2022 
Common stock   75,094,943    33,904,329 
Series A preferred stock (as converted)   1,564,505    1,575,004 
Series B preferred stock (as converted)   
-
    19,253,920 
Warrants   6,391,024    8,594,796 
Stock options   13,595,929    5,575,528 
Total fully diluted common shares   96,646,401    68,903,577 
v3.23.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Schedule of Common Stock Equivalents The Company had the following common stock equivalents at September 30, 2023 and 2022:
   September 30 
   2023   2022 
Common stock   75,094,943    33,904,329 
Series A preferred stock (as converted)   1,564,505    1,575,004 
Series B preferred stock (as converted)   
-
    19,253,920 
Warrants   6,391,024    8,594,796 
Stock options   13,595,929    5,575,528 
Total fully diluted common shares   96,646,401    68,903,577 
v3.23.3
Business Combinations (Tables)
9 Months Ended
Sep. 30, 2023
Business Combinations [Abstract]  
Schedule of Adjusted Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed By the Company The following table summarizes the adjusted acquisition date fair values of assets acquired and liabilities assumed by the Company, including the final results of the analysis performed by the Third Party Valuation Expert for the intangibles:
Purchase price, net of cash acquired  $81,939,939 
Less     
Prepaid expenses   16,109 
Fixed assets at cost   116,315 
Security deposits   97,768 
Non-compete agreement with founder   2,722,000 
Website domain, trade name and trademark   969,000 
Technology and licensed patents   12,200,000 
Accounts payable and other current liabilities   (2,888,246)
Goodwill  $68,706,993 

 

Schedule of the Summarizes Changes of Intangibles The following table summarizes the changes of intangibles, which resulted in an increase to goodwill of $9,581,220 compared to initial purchase price allocation estimates reported in the Company’s Form 10-Q: Quarterly report for quarter ending June 30, 2022.
   Initial
Valuation
   Final   Increase 
Intangible Assets  Estimate   Valuation   (Decrease) 
Customer relationships  $10,000,000   $
-
   $(10,000,000)
Non-compete agreement with founder   500,000    2,722,000    2,222,000 
Website domain, trade name and trademark   1,000,000    969,000    (31,000)
Employment agreements   2,250,000    
-
    (2,250,000)
Technology and licensed patents   11,722,220    12,200,000    477,780 
Total  $25,472,220   $15,891,000    (9,581,220)
v3.23.3
Intangible Assets and Goodwill (Tables)
9 Months Ended
Sep. 30, 2023
Intangible Assets and Goodwill [Abstract]  
Schedule of Amounts Related to Intangible As a result of the merger with QPhoton, the Company has the following amounts related to intangible assets:
   Intangible Assets as of:     
   September 30,   December 31,   Amortizable 
Amortizable Intangible Assets  2023   2022   Life 
Customer relationships   
-
    10,000,000    3 years 
Non-compete agreement with founder   2,722,000    500,000    3 years 
Website domain, trade name and trademark   969,000    1,000,000    5 years 
Employment agreements   
-
    2,250,000    2 years 
Technology and licensed patents   12,200,000    11,722,220    10 years 
Less: accumulated amortization   (3,791,987)   (3,248,495)     
Net intangible assets  $12,099,013   $22,223,725      

 

Schedule of Aggregate Amortization Expense The Company expects future amortization expense to be the following:
   Amortization 
Balance of 2023  $2,132,993 
2024   2,843,991 
2025   2,352,518 
2026   1,936,657 
2027   1,831,682 
Thereafter (2028-2032)   2,423,167 
Total  $12,099,013 
Schedule of Changes in Goodwill The following table provides a summary of the changes in goodwill for the periods ended September 30, 2023 and December 31, 2022:
   September 30,   December 31, 
   2022   2022 
Goodwill, at beginning of year  $59,125,773   $
-
 
Goodwill additions or adjustments   9,581,220    59,125,773 
Goodwill reduction or impairment   3,785,699    
-
 
Goodwill, at end of year  $64,921,294   $59,125,773 
v3.23.3
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2023
Income Taxes [Abstract]  
Schedule of Tax Basis of Existing Assets and Liabilities Under the asset and liability method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities.
   September 30, 
   2023   2022 
Net operating loss carry-forwards  $13,136,072   $8,369,585 
Valuation allowance   (13,136,072)   (8,369,585)
Net deferred tax assets  $
-
   $
-
 
v3.23.3
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2023
Property and Equipment [Abstract]  
Schedule of Property and Equipment Property and Equipment
   September 30,   December 31, 
Classification  2023   2022 
Hardware & Equipment  $3,171,835   $1,026,829 
Software   38,484    18,889 
Total cost of property and equipment   3,210,319    1,045,718 
Accumulated depreciation   252,032    70,549 
Property and equipment, net  $2,958,287   $975,169 
Schedule of Estimated Useful Life The Company acquired $2,164,601 of property and equipment during the nine months ended September 30, 2023. It is the Company’s policy to capitalize purchases of property and equipment with a cost of $2,500 or more that benefit future periods.
   Estimated
Useful Life
(Years)
 
Computer and laboratory equipment  5 
Network equipment  4 
Minor equipment  3 
Furniture and fixtures  7 
Software  3 
Leasehold improvements  5 
v3.23.3
Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Stock Based Compensation [Abstract]  
Schedule of Grant-Date Fair Value of Stock Options Granted The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:
   Nine and Twelve
Months Ended
  
   September 30,  December 31,  
   2023  2022  
Exercise price  $ 1.35 – 1.84  $ 5.20 – 12.72  
Risk-free interest rate   4.68 – 4.81%  0.04 – 0.08% 
Expected volatility   200 – 214%  390 – 415% 
Expected dividend yield   0%  0% 
Expected life of options (in years)   5.0   5.0  
Schedule of Option Activity The following table summarizes the Company’s option activity since December 31, 2022:
       Weighted     
       Average   Contractual 
   Number of   Exercise   Term 
   Shares   Price   (in years) 
Outstanding as of December 31, 2022   9,601,237   $3.42    4.0 
Granted   4,342,500    1.42    5.0 
Exercised   
-
    
-
    
-
 
Forfeited   347,808    5.77    
-
 
Outstanding as of September 30, 2023   13,595,929   $2.72    3.6 
Vested as of September 30, 2023   7,857,651   $3.37    3.3 

 

Schedule of Exercise Price Range The following table summarizes the exercise price range as of September 30, 2023:
Exercise Price   Outstanding Options   Exercisable Options 
$1.00    408,970    408,970 
$1.35    3,750,000    
-
 
$1.45    225,000    225,000 
$1.67    50,000    16,665 
$1.84    592,500    300,000 
$1.95    280,000    280,000 
$2.37    5,090,459    4,388,447 
$2.40    1,055,000    525,006 
$2.56    287,500    95,822 
$2.61    150,000    97,226 
$3.58    65,000    43,335 
$3.98    66,000    66,000 
$5.69    12,500    12,500 
$5.70    25,000    16,667 
$6.49    50,000    33,333 
$6.85    650,000    566,675 
$7.00    18,000    12,000 
$7.55    7,500    7,500 
$8.85    100,000    66,670 
$10.00    650,000    650,000 
$11.51    50,000    33,335 
$11.65    12,500    12,500 
      13,595,929    7,857,651 
Schedule of Statements of Operations and Comprehensive Loss The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss:
   Nine and Twelve
Months Ended
 
   September 30,
2023
   December 31,
2022
 
Research and development   2,273,846    2,758,465 
General and administrative   3,619,450    15,003,002 
Total stock-based compensation  $5,893,296   $17,761,467 
Schedule of Warrants Outstanding The following table summarizes the warrants outstanding at September 30, 2023:
Issuance Date  Expiration Date  Exercise Price   Issued   Exercised   Forfeited /
Canceled
   Warrants
Outstanding
 
August 18, 2020  August 18, 2025  $2.00    171,000    (150,000)   
-
    21,000 
November 15, 2021  November 15, 2023  $7.00    1,545,459    
-
    
-
    1,545,459 
June 16, 2022  May 9, 2027  $0.0001    6,325,503    
-
    (1,500,938)   4,824,565 
v3.23.3
Operating Leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Undiscounted Future Minimum Lease Payments under these Operating Lease The table below reconciles the undiscounted future minimum lease payments under these operating leases to the total operating lease liabilities recognized on the consolidated balance sheet as of September 30, 2023:
Year  Lease
Payments
Due
 
Balance of 2023  $47,135 
2024  $344,732 
2025  $341,081 
2026  $349,608 
2027  $267,092 
Less: imputed Interest  $(301,334)
Present Value of operating lease liabilities  $1,048,313 
Schedule of Other Information Related to Operating Lease Liabilities Other information related to operating lease liabilities consists of the following:
   Six and Twelve
Months Ended
 
   September 30,
2023
   December 31,
2022
 
         
Cash paid for operating lease liabilities  $314,498   $125,238 
Weighted average remaining lease term in years   3.9    4.7 
Weighted average discount rate   10%   10%
v3.23.3
Nature of the Organization and Business (Details) - USD ($)
9 Months Ended
Sep. 30, 2023
Aug. 17, 2023
Dec. 31, 2022
Jul. 20, 2018
Nature of the Organization and Business [Line Items]        
Common stock, par value (in Dollars per share) $ 0.0001   $ 0.0001  
Sale of stocks $ 100,000,000      
Common stock value $ 7,510   $ 5,596  
Shares of common stock (in Shares) 15,290,513      
Common Stock [Member]        
Nature of the Organization and Business [Line Items]        
Aggregate offering price $ 50,000,000 $ 27,362,717    
Corporate History [Member]        
Nature of the Organization and Business [Line Items]        
Common stock, par value (in Dollars per share)       $ 0.0001
ATM Agreement [Member]        
Nature of the Organization and Business [Line Items]        
Liquidity utilized availability 26,500,000      
ATM Agreement [Member] | Minimum [Member]        
Nature of the Organization and Business [Line Items]        
Common stock value   25,000,000    
ATM Agreement [Member] | Maximum [Member]        
Nature of the Organization and Business [Line Items]        
Common stock value   $ 50,000,000    
2022 Shelf [Member]        
Nature of the Organization and Business [Line Items]        
Liquidity utilized 23,500,000      
Liquidity utilized availability $ 76,500,000      
v3.23.3
Significant Accounting Policies (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
Consolidation [Member]  
Significant Accounting Policies (Details) [Line Items]  
Revenues $ 283,154
Net loss 21,424,504
Net cash used in operations 14,591,833
Working capital deficit 20,589
Accumulated deficit 141,412,285
Morgan Stanley [Member]  
Significant Accounting Policies (Details) [Line Items]  
Invested market fund $ 7,171,302
v3.23.3
Significant Accounting Policies (Details) - Schedule of Common Stock Equivalents - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cash and Cash Equivalents [Line Items]        
Common stock 75,094,943 33,904,329 75,094,943 33,904,329
Warrants     6,391,024 8,594,796
Stock options     13,595,929 5,575,528
Total fully diluted common shares 96,646,401 68,903,577 96,646,401 68,903,577
Series A preferred stock (as converted) [Member]        
Cash and Cash Equivalents [Line Items]        
Preferred stock (as converted)     1,564,505 1,575,004
Series B preferred stock (as converted) [Member]        
Cash and Cash Equivalents [Line Items]        
Preferred stock (as converted)     19,253,920
v3.23.3
Business Combinations (Details) - USD ($)
6 Months Ended 9 Months Ended
Jun. 30, 2022
Apr. 01, 2022
Jun. 30, 2023
Sep. 30, 2023
Jun. 16, 2023
Mar. 01, 2023
Jan. 01, 2023
Dec. 31, 2022
Sep. 23, 2022
Jul. 05, 2022
Feb. 18, 2022
Business Combinations [Line Items]                      
Common stock shares (in Shares)       7,028,337           16,000,000  
Common stock, par value (in Dollars per share)       $ 0.0001              
Shares of common stock (in Shares)       1,000,000              
Maturity term       5 years              
Percentage of interest rate   15.00%   2.80%         10.00%   6.00%
Volatility       3.54%              
Exercise pricec (in Dollars per share)       $ 0.00001              
Transaction amount       $ 83,083,868              
Intangibles increase to goodwill $ 9,581,220   $ 9,581,220                
Purchase price       $ 68,700,000              
Principal balance   $ 1,250,000                  
Loans assumed   $ 2,500,000                  
Extension year           1 year          
Common Stock [Member]                      
Business Combinations [Line Items]                      
Shares of common stock (in Shares)       36,600,823     17,000,000        
Replacement cost method [Member]                      
Business Combinations [Line Items]                      
Fair value       $ 1,912,000              
Intangible assets       $ 2,250,000              
QPhoton [Member]                      
Business Combinations [Line Items]                      
Promissory note principal amount                     $ 1,250,000
Warrant [Member]                      
Business Combinations [Line Items]                      
Shares of common stock (in Shares)       7,028,337              
Customer Relationships [Member]                      
Business Combinations [Line Items]                      
Customer relationships       $ 10,000,000              
Estimate of intangible assets             $ 10,000,000      
Patented Technology [Member]                      
Business Combinations [Line Items]                      
Intangible assets       477,780              
Estimate of intangible assets       11,722,220              
Fair value of attributable to technology and licensed patents       12,200,000              
QPhoton [Member]                      
Business Combinations [Line Items]                      
Intangible assets       31,000              
Estimate of intangible assets       1,000,000              
Fair value of attributable to trade name and trademark       $ 969,000              
Series B Convertible Preferred [Member]                      
Business Combinations [Line Items]                      
Preferred stock shares issued (in Shares)       2,377,028              
Shares of common stock (in Shares)       2,377,028              
Purchase price approximately       $ 83,100,000              
Non-Compete Agreement [Member]                      
Business Combinations [Line Items]                      
Fair value       2,722,000              
Intangible assets       2,222,000              
Estimate of intangible assets       $ 500,000              
Common Stock [Member]                      
Business Combinations [Line Items]                      
Share price (in Dollars per share)         $ 2.27            
Merger with QPhoton, Inc. [Member]                      
Business Combinations [Line Items]                      
Common stock shares (in Shares)       5,802,206              
Merger with QPhoton, Inc. [Member] | Series B Convertible Preferred [Member]                      
Business Combinations [Line Items]                      
Preferred stock, par value (in Dollars per share)       $ 0.0001              
QPhoton [Member]                      
Business Combinations [Line Items]                      
Principal balance                     $ 1,250,000
v3.23.3
Business Combinations (Details) - Schedule of Adjusted Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed By the Company
9 Months Ended
Sep. 30, 2023
USD ($)
Schedule of Adjusted Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed by the Company [Abstract]  
Purchase price, net of cash acquired $ 81,939,939
Less  
Prepaid expenses 16,109
Fixed assets at cost 116,315
Security deposits 97,768
Non-compete agreement with founder 2,722,000
Website domain, trade name and trademark 969,000
Technology and licensed patents 12,200,000
Accounts payable and other current liabilities (2,888,246)
Goodwill $ 68,706,993
v3.23.3
Business Combinations (Details) - Schedule of the Summarizes Changes of Intangibles
3 Months Ended
Jun. 30, 2023
USD ($)
Initial Valuation Estimate [Member]  
Finite-Lived Intangible Assets [Line Items]  
Initial Valuation Estimate $ 25,472,220
Final Valuation [Member]  
Finite-Lived Intangible Assets [Line Items]  
Final Valuation 15,891,000
Increase Decrease [Member]  
Finite-Lived Intangible Assets [Line Items]  
Increase (Decrease) (9,581,220)
Customer Relationships [Member] | Initial Valuation Estimate [Member]  
Finite-Lived Intangible Assets [Line Items]  
Initial Valuation Estimate 10,000,000
Customer Relationships [Member] | Final Valuation [Member]  
Finite-Lived Intangible Assets [Line Items]  
Final Valuation
Customer Relationships [Member] | Increase Decrease [Member]  
Finite-Lived Intangible Assets [Line Items]  
Increase (Decrease) (10,000,000)
Non-compete agreement with founder [Member] | Initial Valuation Estimate [Member]  
Finite-Lived Intangible Assets [Line Items]  
Initial Valuation Estimate 500,000
Non-compete agreement with founder [Member] | Final Valuation [Member]  
Finite-Lived Intangible Assets [Line Items]  
Final Valuation 2,722,000
Non-compete agreement with founder [Member] | Increase Decrease [Member]  
Finite-Lived Intangible Assets [Line Items]  
Increase (Decrease) 2,222,000
Website domain, trade name and trademark [Member] | Initial Valuation Estimate [Member]  
Finite-Lived Intangible Assets [Line Items]  
Initial Valuation Estimate 1,000,000
Website domain, trade name and trademark [Member] | Final Valuation [Member]  
Finite-Lived Intangible Assets [Line Items]  
Final Valuation 969,000
Website domain, trade name and trademark [Member] | Increase Decrease [Member]  
Finite-Lived Intangible Assets [Line Items]  
Increase (Decrease) (31,000)
Employment agreements [Member] | Initial Valuation Estimate [Member]  
Finite-Lived Intangible Assets [Line Items]  
Initial Valuation Estimate 2,250,000
Employment agreements [Member] | Final Valuation [Member]  
Finite-Lived Intangible Assets [Line Items]  
Final Valuation
Employment agreements [Member] | Increase Decrease [Member]  
Finite-Lived Intangible Assets [Line Items]  
Increase (Decrease) (2,250,000)
Technology and licensed patents [Member] | Initial Valuation Estimate [Member]  
Finite-Lived Intangible Assets [Line Items]  
Initial Valuation Estimate 11,722,220
Technology and licensed patents [Member] | Final Valuation [Member]  
Finite-Lived Intangible Assets [Line Items]  
Final Valuation 12,200,000
Technology and licensed patents [Member] | Increase Decrease [Member]  
Finite-Lived Intangible Assets [Line Items]  
Increase (Decrease) $ 477,780
v3.23.3
Intangible Assets and Goodwill (Details) - USD ($)
6 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Intangible Assets and Goodwill [Line Items]        
Goodwill     $ 65,106,678  
Realized impairments     3,785,699  
Increased goodwill of intangible assets $ 9,581,220 $ 9,581,220    
Goodwill [Member]        
Intangible Assets and Goodwill [Line Items]        
Intangible assets     $ 543,492 $ 3,248,495
v3.23.3
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible [Line Items]    
Less: accumulated amortization $ (3,791,987) $ (3,248,495)
Net intangible assets 12,099,013 22,223,725
Customer relationships [Member]    
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible [Line Items]    
Intangible Assets 10,000,000
Amortizable Life 3 years  
Non-compete agreement with founder [Member]    
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible [Line Items]    
Intangible Assets $ 2,722,000 500,000
Amortizable Life 3 years  
Website domain, trade name and trademark [Member]    
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible [Line Items]    
Intangible Assets $ 969,000 1,000,000
Amortizable Life 5 years  
Employment agreements [Member]    
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible [Line Items]    
Intangible Assets 2,250,000
Amortizable Life 2 years  
Technology and licensed patents [Member]    
Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible [Line Items]    
Intangible Assets $ 12,200,000 $ 11,722,220
Amortizable Life 10 years  
v3.23.3
Intangible Assets and Goodwill (Details) - Schedule of Aggregate Amortization Expense
Sep. 30, 2023
USD ($)
Schedule of aggregate amortization expense [Abstract]  
Balance of 2023 $ 2,132,993
2024 2,843,991
2025 2,352,518
2026 1,936,657
2027 1,831,682
Thereafter (2028-2032) 2,423,167
Total $ 12,099,013
v3.23.3
Intangible Assets and Goodwill (Details) - Schedule of Changes in Goodwill - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of the changes in goodwill [Abstract]    
Goodwill, at beginning of year $ 59,125,773
Goodwill additions or adjustments 9,581,220 59,125,773
Goodwill reduction or impairment 3,785,699
Goodwill, at end of year $ 64,921,294 $ 59,125,773
v3.23.3
Income Taxes (Details)
Sep. 30, 2023
USD ($)
Income Taxes [Abstract]  
Net operating loss carry forwards $ 13,136,072
v3.23.3
Income Taxes (Details) - Schedule of Tax Basis of Existing Assets and Liabilities - USD ($)
Sep. 30, 2023
Sep. 30, 2022
Schedule of tax basis of existing assets and liabilities [Abstract]    
Net operating loss carry-forwards $ 13,136,072 $ 8,369,585
Valuation allowance (13,136,072) (8,369,585)
Net deferred tax assets
v3.23.3
Property and Equipment (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
Property and Equipment [Abstract]  
Property and equipment acquisitions $ 2,164,601
Property and equipment cost $ 2,500
v3.23.3
Property and Equipment (Details) - Schedule of Property and Equipment - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of property and equipment [Abstract]    
Total cost of property and equipment $ 3,210,319 $ 1,045,718
Accumulated depreciation 252,032 70,549
Property and equipment, net 2,958,287 975,169
Hardware & Equipment [Member]    
Schedule of property and equipment [Abstract]    
Total cost of property and equipment 3,171,835 1,026,829
Software [Member]    
Schedule of property and equipment [Abstract]    
Total cost of property and equipment $ 38,484 $ 18,889
v3.23.3
Property and Equipment (Details) - Schedule of Estimated Useful Life
Sep. 30, 2023
Computer and laboratory equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Estimated Useful Life 5 years
Network equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Estimated Useful Life 4 years
Minor equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Estimated Useful Life 3 years
Furniture and fixtures [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Estimated Useful Life 7 years
Software [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Estimated Useful Life 3 years
Leasehold improvements [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Estimated Useful Life 5 years
v3.23.3
Loans (Details) - USD ($)
9 Months Ended
Sep. 30, 2023
Jun. 06, 2023
May 16, 2023
Sep. 23, 2022
Jun. 16, 2022
Apr. 01, 2022
Feb. 18, 2022
Jul. 09, 2021
Mar. 23, 2021
Mar. 01, 2021
Loans [Abstract]                    
Convertible promissory notes               $ 150,000 $ 150,000 $ 200,592
Note payable total amount               $ 500,592 $ 500,592 $ 500,592
Interest rate 2.80%     10.00%   15.00% 6.00%      
Cash proceeds $ 375,000                  
Principal balance   $ 500,000 $ 2,000,000 $ 8,250,000 $ 53,568.44          
Original issue discount       $ 750,000            
Percentage of outstanding balance       120.00%            
Redeemption amount 750,000                  
Investor redeemed outstanding balance $ 4,750,000                  
Interest rate 15.00%                  
Minimum [Member]                    
Loans [Abstract]                    
Interest rate   10.00%                
Maximum [Member]                    
Loans [Abstract]                    
Interest rate   15.00%                
millionways [Member]                    
Loans [Abstract]                    
Acquire percentage     100.00%              
BV Advisory Partners, LLC [Member]                    
Loans [Abstract]                    
Interest rate 6.00%                  
Matured year 2 years                  
Cash proceeds $ 125,041                  
v3.23.3
Capital Stock (Details) - USD ($)
1 Months Ended 9 Months Ended
Feb. 09, 2023
Jun. 13, 2022
Nov. 17, 2021
Jun. 16, 2022
Nov. 30, 2021
Aug. 31, 2020
Sep. 30, 2023
May 03, 2023
Jan. 20, 2023
Dec. 31, 2022
Oct. 11, 2022
Capital Stock [Line Items]                      
Purchase warrants       6,325,503 1,545,459 171,000          
Percent rate             10.00%        
Conversion price per share (in Dollars per share)             $ 5.5        
Exercise price per share (in Dollars per share)             $ 7        
Shares of common stock                     155,000
Common stock , issued shares             23,600 853,600      
Series A Convertible Preferred Stock [Member]                      
Capital Stock [Line Items]                      
Purchased shares     1,545,459                
Convertible Preferred stock, par value (in Dollars per share)     $ 0.0001       $ 0.0001     $ 0.0001  
Purchase warrants     1,545,459                
Aggregate purchase price (in Dollars)     $ 8,500,000                
Falcon Capital Partners [Member] | Series A Convertible Preferred Stock [Member]                      
Capital Stock [Line Items]                      
Shares of common stock   45,455                  
Accrued dividend shares   47,728                  
Greenfield Children, LLC, [Member] | Series A Convertible Preferred Stock [Member]                      
Capital Stock [Line Items]                      
Accrued dividend shares 11,096                    
Converted shares 10,000                    
Draper, Inc [Member]                      
Capital Stock [Line Items]                      
Shares of common stock                 750,000    
Carriage House Capital, Inc [Member]                      
Capital Stock [Line Items]                      
Shares of common stock                 750,000    
Ascendiant Capital [Member]                      
Capital Stock [Line Items]                      
Shares of common stock             15,290,513        
Average price per share (in Dollars per share)             $ 1.53        
Issuance of gross proceeds (in Dollars)             $ 23,469,560        
Fee percentage             3.00%        
v3.23.3
Stock Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 9 Months Ended
Jun. 16, 2022
Nov. 30, 2021
Aug. 31, 2020
Sep. 30, 2023
Jan. 01, 2023
Jul. 05, 2022
Dec. 31, 2021
Stock Based Compensation [Line Items]              
Shares of common stock       7,028,337   16,000,000  
Shares issued       3,000,000      
Shares issuance       1,000,000      
(in Dollars per share)       $ 1.42     $ 2.38
Common stock options (in Dollars)       $ 7.0      
Recognized over a period       4 years 3 months 18 days      
Issued warrants shares 6,325,503 1,545,459 171,000        
Exercise price per share (in Dollars per share) $ 0.0001 $ 7 $ 2        
Common Stock [Member]              
Stock Based Compensation [Line Items]              
Shares issuance       36,600,823 17,000,000    
2019 Equity and Incentive Plan[Member]              
Stock Based Compensation [Line Items]              
Shares of common stock       3,000,000      
Options 2022 [Member]              
Stock Based Compensation [Line Items]              
Shares of common stock       13,595,929      
v3.23.3
Stock Based Compensation (Details) - Schedule of Grant-Date Fair Value of Stock Options Granted - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Stock Based Compensation (Details) - Schedule of Grant-Date Fair Value of Stock Options Granted [Line Items]    
Expected dividend yield 0.00% 0.00%
Expected life of options (in years) 5 years 5 years
Minimum [Member]    
Stock Based Compensation (Details) - Schedule of Grant-Date Fair Value of Stock Options Granted [Line Items]    
Exercise price (in Dollars per share) $ 1.35 $ 5.2
Risk-free interest rate 4.68% 0.04%
Expected volatility 200.00% 390.00%
Maximum [Member]    
Stock Based Compensation (Details) - Schedule of Grant-Date Fair Value of Stock Options Granted [Line Items]    
Exercise price (in Dollars per share) $ 1.84 $ 12.72
Risk-free interest rate 4.81% 0.08%
Expected volatility 214.00% 415.00%
v3.23.3
Stock Based Compensation (Details) - Schedule of Option Activity
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Schedule of option activity [Abstract]  
Weighted Average Number of Shares, Outstanding Beginning | shares 9,601,237
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 3.42
Contractual Term, Outstanding Beginning 4 years
Weighted Average Number of Shares, Granted | shares 4,342,500
Weighted Average Exercise Price, Granted | $ / shares $ 1.42
Contractual Term, Granted 5 years
Weighted Average Number of Shares, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Contractual Term, Exercised
Weighted Average Number of Shares, Forfeited | shares 347,808
Weighted Average Exercise Price, Forfeited | $ / shares $ 5.77
Forfeited
Weighted Average Number of Shares, Outstanding Ending | shares 13,595,929
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 2.72
Contractual Term, Outstanding Ending 3 years 7 months 6 days
Weighted Average Number of Shares, Vested | shares 7,857,651
Weighted Average Exercise Price, Vested | $ / shares $ 3.37
Contractual Term, Vested 3 years 3 months 18 days
v3.23.3
Stock Based Compensation (Details) - Schedule of Exercise Price Range
Sep. 30, 2023
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding Options 13,595,929
Exercisable Options 7,857,651
Exercise Price 1.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1
Outstanding Options 408,970
Exercisable Options 408,970
Exercise price 1.35 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1.35
Outstanding Options 3,750,000
Exercisable Options
Exercise Price 1.45 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1.45
Outstanding Options 225,000
Exercisable Options 225,000
Exercise Price 1.67 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1.67
Outstanding Options 50,000
Exercisable Options 16,665
Exercise Price 1.84 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1.84
Outstanding Options 592,500
Exercisable Options 300,000
Exercise Price 1.95 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1.95
Outstanding Options 280,000
Exercisable Options 280,000
Exercise Price 2.37 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 2.37
Outstanding Options 5,090,459
Exercisable Options 4,388,447
Exercise Price 2.40 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 2.4
Outstanding Options 1,055,000
Exercisable Options 525,006
Exercise Price 2.56 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 2.56
Outstanding Options 287,500
Exercisable Options 95,822
Exercise Price 2.61 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 2.61
Outstanding Options 150,000
Exercisable Options 97,226
Exercise Price 3.58 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 3.58
Outstanding Options 65,000
Exercisable Options 43,335
Exercise Price 3.98 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 3.98
Outstanding Options 66,000
Exercisable Options 66,000
Exercise Price 5.69 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 5.69
Outstanding Options 12,500
Exercisable Options 12,500
Exercise Price 5.70 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 5.7
Outstanding Options 25,000
Exercisable Options 16,667
Exercise Price 6.49 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 6.49
Outstanding Options 50,000
Exercisable Options 33,333
Exercise Price 6.85 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 6.85
Outstanding Options 650,000
Exercisable Options 566,675
Exercise Price 7.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 7
Outstanding Options 18,000
Exercisable Options 12,000
Exercise Price 7.55 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 7.55
Outstanding Options 7,500
Exercisable Options 7,500
Exercise Price 8.85 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 8.85
Outstanding Options 100,000
Exercisable Options 66,670
Exercise Price 10.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 10
Outstanding Options 650,000
Exercisable Options 650,000
Exercise Price 11.51 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 11.51
Outstanding Options 50,000
Exercisable Options 33,335
Exercise Price 11.65 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 11.65
Outstanding Options 12,500
Exercisable Options 12,500
v3.23.3
Stock Based Compensation (Details) - Schedule of Statements of Operations and Comprehensive Loss - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of Statements of Operations and Comprehensive Loss [Abstract]    
Research and development $ 2,273,846 $ 2,758,465
General and administrative 3,619,450 15,003,002
Total stock-based compensation $ 5,893,296 $ 17,761,467
v3.23.3
Stock Based Compensation (Details) - Schedule of Warrants Outstanding
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Exercise Price 2.00 [Member]  
Class of Warrant or Right [Line Items]  
Issuance Date Aug. 18, 2020
Expiration Date Aug. 18, 2025
Exercise Price (in Dollars per share) | $ / shares $ 2
Issued 171,000
Exercised (150,000)
Forfeited / Canceled
Warrants Outstanding 21,000
Exercise Price 7.00 [Member]  
Class of Warrant or Right [Line Items]  
Issuance Date Nov. 15, 2021
Expiration Date Nov. 15, 2023
Exercise Price (in Dollars per share) | $ / shares $ 7
Issued 1,545,459
Exercised
Forfeited / Canceled
Warrants Outstanding 1,545,459
Exercise Price 0.0001 [Member]  
Class of Warrant or Right [Line Items]  
Issuance Date Jun. 16, 2022
Expiration Date May 09, 2027
Exercise Price (in Dollars per share) | $ / shares $ 0.0001
Issued 6,325,503
Exercised
Forfeited / Canceled (1,500,938)
Warrants Outstanding 4,824,565
v3.23.3
Operating Leases (Details) - Schedule of Undiscounted Future Minimum Lease Payments Under these Operating Lease
Sep. 30, 2023
USD ($)
Schedule of Undiscounted Future Minimum Lease Payments under these Operating Lease [Abstract]  
Balance of 2023 $ 47,135
2024 344,732
2025 341,081
2026 349,608
2027 267,092
Less: imputed Interest (301,334)
Present Value of operating lease liabilities $ 1,048,313
v3.23.3
Operating Leases (Details) - Schedule of Other Information Related to Operating Lease Liabilities - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of Other Information Related to Operating Lease Liabilities [Abstract]    
Cash paid for operating lease liabilities $ 314,498 $ 125,238
Weighted average remaining lease term in years 3 years 10 months 24 days 4 years 8 months 12 days
Weighted average discount rate 10.00% 10.00%
v3.23.3
License Agreement – Stevens Institute of Technology (Details)
9 Months Ended
Sep. 30, 2023
License Agreement – Stevens Institute of Technology [Abstract]  
Consideration agreement, description As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35,000 within 30 days of execution of the agreement, (ii) $28,000 within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the outstanding equity of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the net sales price of each licensed product sold or licensed by the company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.
v3.23.3
Subsequent Events (Details) - Subsequent Event [Member] - USD ($)
1 Months Ended
Oct. 03, 2023
Nov. 10, 2023
Oct. 31, 2023
Subsequent Events [Line Items]      
Description of united nations news currently contaminated According to United Nations News, currently there are approximately 70 countries and territories contaminated by roughly 110 million landmines. Landmines kill and maim up to 1,000 to 2,000 people every month, most of whom are civilians and children.    
Cumulative redemption amount   $ 2,786,528  
Minimum [Member]      
Subsequent Events [Line Items]      
Percentage of proprietary capabilities     80.00%
Maximum [Member]      
Subsequent Events [Line Items]      
Percentage of proprietary capabilities     95.00%
Streeterville [Member]      
Subsequent Events [Line Items]      
Repaid of principal amount   1,500,000  
Cumulative redemption amount   $ 6,250,000  

Quantum Computing (NASDAQ:QUBT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Quantum Computing Charts.
Quantum Computing (NASDAQ:QUBT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Quantum Computing Charts.